WO2000050115A9 - Guide wire system for rf recanalization of vascular blockages - Google Patents
Guide wire system for rf recanalization of vascular blockagesInfo
- Publication number
- WO2000050115A9 WO2000050115A9 PCT/US2000/004475 US0004475W WO0050115A9 WO 2000050115 A9 WO2000050115 A9 WO 2000050115A9 US 0004475 W US0004475 W US 0004475W WO 0050115 A9 WO0050115 A9 WO 0050115A9
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- guide wire
- catheter
- lumen
- centering
- blood vessel
- Prior art date
Links
- 230000002792 vascular Effects 0.000 title 1
- 238000002679 ablation Methods 0.000 claims abstract description 106
- 210000004204 blood vessel Anatomy 0.000 claims abstract description 79
- 230000007246 mechanism Effects 0.000 claims abstract description 68
- 238000009413 insulation Methods 0.000 claims abstract description 16
- 230000000472 traumatic effect Effects 0.000 claims abstract description 13
- 238000004891 communication Methods 0.000 claims abstract description 12
- 239000012530 fluid Substances 0.000 claims abstract description 10
- 238000010438 heat treatment Methods 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims description 52
- 230000001225 therapeutic effect Effects 0.000 claims description 10
- 238000002560 therapeutic procedure Methods 0.000 claims description 6
- 238000002399 angioplasty Methods 0.000 claims description 4
- 239000002872 contrast media Substances 0.000 claims description 4
- 229910001000 nickel titanium Inorganic materials 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 230000003213 activating effect Effects 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000012781 shape memory material Substances 0.000 claims description 3
- 239000004020 conductor Substances 0.000 claims description 2
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 abstract description 24
- 230000036961 partial effect Effects 0.000 description 32
- 239000000463 material Substances 0.000 description 19
- 239000008280 blood Substances 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 14
- 239000003990 capacitor Substances 0.000 description 13
- 238000009760 electrical discharge machining Methods 0.000 description 11
- 230000008569 process Effects 0.000 description 10
- 210000005166 vasculature Anatomy 0.000 description 8
- 238000004804 winding Methods 0.000 description 7
- 230000010339 dilation Effects 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- -1 e.g. Substances 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 238000013461 design Methods 0.000 description 4
- 210000004907 gland Anatomy 0.000 description 4
- 239000004642 Polyimide Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229920001721 polyimide Polymers 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- 229910000531 Co alloy Inorganic materials 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 229920002614 Polyether block amide Polymers 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000010292 electrical insulation Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 2
- 229910052721 tungsten Inorganic materials 0.000 description 2
- 239000010937 tungsten Substances 0.000 description 2
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 229920000339 Marlex Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000005249 arterial vasculature Anatomy 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 238000005422 blasting Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007887 coronary angioplasty Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007831 electrophysiology Effects 0.000 description 1
- 238000002001 electrophysiology Methods 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000013021 overheating Methods 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000012858 resilient material Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 229910001256 stainless steel alloy Inorganic materials 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22038—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with a guide wire
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22094—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for for crossing total occlusions, i.e. piercing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/0022—Balloons
- A61B2018/0025—Multiple balloons
- A61B2018/00261—Multiple balloons arranged in a line
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00273—Anchoring means for temporary attachment of a device to tissue
- A61B2018/00279—Anchoring means for temporary attachment of a device to tissue deployable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00273—Anchoring means for temporary attachment of a device to tissue
- A61B2018/00279—Anchoring means for temporary attachment of a device to tissue deployable
- A61B2018/00285—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00404—Blood vessels other than those in or around the heart
- A61B2018/0041—Removal of thrombosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00404—Blood vessels other than those in or around the heart
- A61B2018/00422—Angioplasty
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00625—Vaporization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/1213—Generators therefor creating an arc
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/1246—Generators therefor characterised by the output polarity
- A61B2018/1253—Generators therefor characterised by the output polarity monopolar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1405—Electrodes having a specific shape
- A61B2018/1435—Spiral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1405—Electrodes having a specific shape
- A61B2018/144—Wire
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1047—Balloon catheters with special features or adapted for special applications having centering means, e.g. balloons having an appropriate shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/09—Guide wires
Definitions
- the present invention is directed to methods and apparatus for recanalizing occlusions, i.e., atherosclerotic plaque build-up, in blood vessels, thereby permitting access to the occlusion by apparatus for resolving and removing the occlusion in the blood vessel in order to improve blood flow therein.
- occlusions i.e., atherosclerotic plaque build-up
- the single largest cause of cardiovascular disease is sclerosis ⁇ a build-up of fatty or calcific deposits in the arterial lumen. These deposits can impair, and in severe cases, totally obstruct, i.e., become an occlusion, the flow of blood through the artery.
- a number of medical devices have been designed to displace, disperse or extract the occlusive deposits. Most of these devices operate over or in conjunction with a guide wire used to navigate the vasculature and traverse the occlusion location. The initial placement of the guide wire can be problematic in cases of total or near-total occlusion.
- Known techniques for traversing a total occlusion involve forcibly advancing a blunt catheter through the occlusive material (the Dotter technique), or using rotational means (orthogonal displacement of friction).
- an electrically conductive guide wire is proximally connected to a radio frequency (RF) generator, which when operated transmits RF energy through the guide wire to a spherical ablation tip. More particularly, the guide wire is first advanced through the vasculature of a patient, via a guiding catheter or guide sheath, until it reaches the occlusive material.
- RF radio frequency
- the RF generator With the spherical ablation tip in contact with the occlusive material, the RF generator is operated and the guide wire tip is advanced through the occlusive material. A therapeutic device used to treat the occlusive disorder is then advanced over the guide wire in accordance with known techniques.
- the electrode tip of the ablative guide wire must be supplied with a potential high enough to ionize or break down the liquid contained in the tissue. This is known as a "spark erosion" process.
- spark erosion With a monopolar guide wire electrode tip used in conjunction with a dispersive electrode or ground pad located on an external portion of the patient's body, an ionizing arc from the electrode tip is used to instantaneously convert the occlusive matter into a plasma state, in effect, vaporizing the tissue into particulate matter that is safely absorbed by the blood stream.
- a lower energy potential may be employed to maintain the plasma conversion as the guide wire tip is moved through the occlusive matter.
- the RF generator system must provide the guide wire electrode tip with sufficient voltage or potential to initiate the spark erosion process.
- Typical RF generators such as those used in electrosurgery or electrophysiology, are capable of generating a high potential, but deliver a constant output level under all load impedance conditions.
- the load impedance seen by the guide wire electrode tip may vary greatly, depending upon the relative liquid content of the body tissue it contacts, i.e., the lower the liquid content, the higher the impedance.
- blood impedance will typically range from 150 to 200 ohm/cm.
- Healthy vessel wall impedance will typically range from 300 to 400 ohm/cm.
- Occlusive tissue impedance on the other hand, depending on the degree of calcification, will normally exceed 600 ohm/cm, ranging from 1000 ohm/cm to as high as 3000 ohm/cm.
- U.S. Patent No. 5,300,068 discloses an RF generator system for selectively providing a train of modulated electrical energy pulses in a modulated continuous wave signal (preferably a cosine squared wave shape) to an electrosurgical electrode disposed on a guide wire, wherein the output impedance of the source of the pulses is continually matched to the load impedance seen by the electrode.
- the Rosar generator system measures the relative electrical energy produced by an arc in response to a given electrical pulse, and compares the relative electrical energy to a predetermined value to determine an energy difference. The energy level of a subsequent pulse is then adjusted to reduce the measured difference towards a pre-selected value.
- this automatic impedance matching compensates for the changing impedance conditions at the electrode, to ensure an efficient power transfer takes place.
- maximum power transfer will occur if the output impedance at the electrode tip is substantially equal to the load impedance of the body tissue (or blood) in contact with the electrode tip.
- the Rosar generator system is relatively complex and, thus, expensive to implement. Further, because the ablation electrode power output is maximized over all impedance levels, overheating of the electrode in the blood pool or when in contact with healthy vessel wall tissue may result, thus damaging the electrode structure and potentially harming the patient.
- the present invention is directed to improved catheter devices and methods for recanalization of an occluded blood vessel within the vasculature of a patient.
- centering mechanisms are provided for properly positioning an ablative guide wire tip within an occluded blood vessel for performing a recanalization of the blood vessel.
- a centering catheter for positioning a guide wire in a blood vessel.
- the centering catheter includes an elongate catheter body having a distal end and an operative lumen.
- the lumen has a distal end opening, such that a guide wire disposed in the lumen may be advanced beyond the distal end opening.
- a centering mechanism operable to secure the distal end of the catheter body within a blood vessel is mounted proximate the distal end of the catheter, such that a distal guide wire tip is positioned in the lumen proximate the distal end opening within the blood vessel. It is preferred that the centering mechanism be capable of positioning the guide wire tip both axially and longitudinally within the vessel lumen.
- the centering mechanism may be variously constructed to optimize the centering of the guide wire ablation tip depending on the blood vessel geometry at the location of the occlusion.
- a segmented, inflatable balloon is employed as the centering mechanism.
- the centering mechanism comprises a resilient support structure disposed within the catheter body proximal to an inflatable balloon.
- the resilient support is pre-shaped into a selected complex geometry , such as, e.g., a helix or a bi-planar wave, to best conform the catheter body to wall of the blood vessel.
- the resilient support is composed of a shape memory material, such as, e.g., Nitinol.
- a preferred method for recanalization of a blood vessel employing a guide wire centering mechanism includes: positioning a conductive guide wire having a distal end ablation tip into a blood vessel, such that the ablation tip is adjacent an occlusion to be traversed; centering the guide wire ablation tip within the blood vessel; conveying radio frequency (RF) RF energy through the guide wire to the distal ablation tip; and advancing the energized ablation tip through the occlusion.
- RF radio frequency
- a catheter for use as, e.g., a centering catheter wherein air trapped in a distal end inflatable body may be readily purged.
- the catheter includes an elongate catheter body having proximal and distal ends.
- An inflatable body defining an interior region is mounted to the catheter body proximate the distal end of the catheter body.
- a first lumen extends through the catheter body and has a distal opening in communication with the interior region.
- a second lumen is disposed (e.g., concentrically) within the first lumen and also has a distal opening in communication with the interior region.
- a pressurized fluid medium is introduced through the first lumen into the interior region, forcing the air back out through the second lumen.
- the first and second lumens terminate at opposite ends of the interior region, so that substantially all of the trapped air is pushed out of the interior region.
- a preferred method includes: placing an insulation tubing over at least a portion of an electrically conductive wire; stretching the tubing to reduce its thickness to a desired level; and heating the stretched tubing to thereby adhere the tubing wire.
- an ablative guide wire assembly includes an elongate conductive guide wire having an ablation tip formed on its distal end, the ablation tip having a generally non-traumatic structure with a discontinuous feature.
- the non-traumatic tip structure may be spherically shaped, wherein the discontinuous feature comprises one or more protrusion(s) or edge(s) formed on the structure to thereby form high current densities at the discontinuous points.
- the high current density provides a co ⁇ esponding high power density, resulting in more efficient tissue ablation.
- a distal portion of the guide wire is shapeable such that the distal portion of the guide wire can better track through, for example, a curved blood vessel lumen.
- electrical energy pulses are supplied from an RF generator to a monopolar guide wire electrode tip in a continuous wave form, each pulse having an initially high spike, but with the RMS voltage maintained at a relatively low level.
- the guide wire ablation system output voltage and impedance are selected in conjunction with the electrode tip geometry (i.e., depending on the particular current density achieved at the electrode tip) to provide for optimal spark erosion when the electrode tip is in contact with high impedance occlusive tissue, while reducing the overall power output when in contact with blood or healthy vessel wall tissue.
- Fig. 1 is a perspective view of a vessel recanalization system
- Fig. 2 is a cut away, partial side view of a first preferred centering catheter used in the vessel recanalization system of Fig. 1;
- Fig. 2A is a cross-sectional view of the centering catheter of Fig. 2 taken along the line 2A-2A;
- Fig. 3 is a partial side view of an another preferred centering catheter of Fig. 2;
- Fig. 3A is a cross-sectional view of the centering catheter of Fig. 3 taken along the line 3A-3A;
- Fig. 4 is a side view of an ablative guide wire employed in the vessel canalization system of Fig. 1;
- Fig. 5 is a plan view of an insulation application machine used to manufacture the ablative guide wire of Fig. 4;
- Fig. 6 is a partial side view of a distal ablation tip employed by the ablative guide wire of in Fig. 4;
- Fig. 6A is a front view of the distal ablation tip of Fig. 6 taken along the line 6A-
- Fig. 7 is a partial side view of another distal ablation tip employed by the ablative guide wire of Fig. 4;
- Fig. 8 is a partial side view of still another distal ablation tip employed by the ablative guide wire shown in Fig. 2;
- Fig. 8A is a front view of the distal ablation tip of Fig. 8 taken along the line 8 A- 8A;
- Fig. 9 is a partial side view of still another distal ablation tip employed by the ablative guide wire of Fig. 4;
- Fig. 10 is a partial side view of still another distal ablation tip employed by the ablative guide wire of Fig. 4;
- Fig. 11 is a perspective view of a proximal adapter, particularly shown mated to the proximal end of the centering catheter of Fig. 2;
- Fig. 12 is a circuit schematic of the generator of Fig. 1;
- Fig. 12A is a voltage wave signal output by the generator system of Fig. 12;
- Figs. 12B-D illustrate the relationships between the system output voltage, current and power, respectively, versus patient tissue load impedance "seen" at the guide wire ablation tip;
- Fig. 12E is a simplified functional block diagram of impedance control elements in an alternate recanalization system
- Fig. 13 is a partial side view of the rectilinear region of a blood vessel during operation of the vessel recanalization system, wherein the distal ablation tip is shown adjacent an occlusion within a rectilinear region of a blood vessel;
- Fig. 14 is a partial side view of the blood vessel of Fig. 13, wherein the centering catheter is introduced over the ablative guide wire of Fig. 4;
- Fig. 15 is a partial side view of the blood vessel of Fig. 13, wherein the centering mechanism is activated to center the ablative guide wire within the blood vessel;
- Fig. 16 is a partial side view of the blood vessel of Fig. 13, wherein the ablative guide wire of Fig. 15 has traversed the occlusion;
- Fig. 17 is a partial side view of the blood vessel of Fig. 13, wherein a PTCA catheter is advanced over the ablative guide wire of Fig. 16;
- Fig. 18 is a partial side view of the blood vessel of Fig. 13, wherein the PTCA catheter of Fig. 17 is operated to dilate the blood vessel;
- Fig. 19 is a cut away, partial side view of another centering catheter employed in the vessel recanalization system of Fig. 1, wherein the centering catheter particularly employs a segmented inflatable/deflatable balloon as a centering mechanism;
- Fig. 20 is a cut away, partial side view of the centering catheter of Fig. 19, wherein the segmented inflatable/deflatable balloon comprises pre-formed segments;
- Fig. 21 is a cut away, partial side view of the centering catheter of Fig. 19, wherein the segmented inflatable/deflatable balloon comprises multiple pieces of material;
- Fig. 22 is a partial side view of the curvilinear region of a blood vessel during operation of the vessel recanalization system of Fig. 1, wherein the centering mechanism is activated to center the ablative guide wire within the blood vessel;
- Fig. 23 is a partial side view of the curvilinear region of a blood vessel during operation of the vessel recanalization system of Fig. 1, wherein the occlusion is traversed by the ablative guide wire in a single ablation step;
- Fig. 24 is a partial side view of the curvilinear region of a blood vessel during operation of the vessel recanalization system of Fig. 1, wherein the occlusion is partially traversed by the ablative guide wire;
- Fig. 25 is a partial side view of the blood vessel of Fig. 24, wherein a PTCA catheter is advanced over the ablative guide wire;
- Fig. 26 is a partial side view of the blood vessel of Fig. 24, wherein the PTCA catheter of Fig. 25 is operated to partially dilate the blood vessel;
- Fig. 27 is a partial side view of the blood vessel of Fig. 24, wherein the occlusion is totally traversed by the ablative guide wire;
- Fig. 28 is a cut away, partial side view of still another centering catheter employed in the vessel recanalization system of Fig. 1, wherein the centering catheter particularly employs a single inflatable/deflatable balloon and a plurality of resilient wires preshaped into a helix as a centering mechanism;
- Fig. 28A is a cross-sectional view of the centering catheter of Fig. 28 taken along the line 28A-28A;
- Fig. 29 is a cut away, partial side view of still another centering catheter employed in the vessel recanalization system of Fig. 1, wherein the centering catheter particularly employs a single inflatable/deflatable balloon and a plurality of resilient wires preshaped into a biplanar wave as a centering mechanism;
- Fig. 30 is a partial side view of the centering catheter of Fig. 28, wherein the centering mechanism is activated to center an ablation tip of an ablative guide wire within a curvilinear region of the blood vessel;
- Fig. 31 is a cut away, partial side view of still another centering catheter employed in the vessel recanalization system of Fig. 1, wherein the centering catheter particularly employs a single inflatable/deflatable balloon as a centering mechanism and a catheter body with coextruded inflation and guide wire lumens;
- Fig. 31 A is a cross-sectional view of the centering catheter of Fig. 31 taken along the line 31A-31A;
- Fig. 32 is a cut away, partial side view of still another centering catheter employed in the vessel recanalization system of Fig. 1, wherein the centering catheter particularly employs a segmented inflatable/deflatable balloon as a centering mechanism and a catheter body with coextruded inflation and guide wire lumens;
- Fig. 33 is a cut away, partial side view of still another centering catheter employed in the vessel recanalization system of Fig. 1, wherein the centering catheter particularly employs a plurality of resilient centering rings as a centering mechanism;
- Fig. 33A is a cross-sectional view of the centering catheter of Fig. 33 taken along the line 33A-33A;
- Fig. 1 depicts a preferred embodiment of a vessel recanalization system 10 constructed in accordance with the present invention.
- the system 10 generally includes a centering catheter 12, an ablative guide wire 14, and a radio frequency (RF) generator 16, which are arranged to facilitate the therapy of a totally occluded blood vessel 250 (shown with an occlusion 252 in Figs. 13-16) within a patient.
- RF radio frequency
- the centering catheter 12 includes an elongated catheter body 18 with a guide wire lumen 20 through which the ablative guide wire 14 is slidingly disposed.
- the ablative guide wire 14 includes a distal ablation tip 22, which may be extended from the distal end of the catheter body 18.
- the centering catheter 12 further includes a centering mechanism 24 mounted to the catheter body 18 adjacent the guide wire lumen 20 for centering the distal ablation tip 22 within the blood vessel 250.
- the proximal end of the ablative guide wire 14 is coupled via a connector 11 to an RF supply cable 13 from the generator 16.
- the generator 16 provides RF energy to the guide wire ablation tip 22 for spark-erosion assisted recanalization of the occlusion 252.
- the energy is returned through a patient return electrode 72, which is also electrically coupled to the generator 16.
- the patient return electrode 72 takes the form of a pad with a substantially large area, so that the delivery of RF energy to the target tissue is maximized.
- a footswitch control 74 is used to control output of the generator 16 - i.e., wherein depression of the footswitch 74 provides a controlled delivery of RF energy from the generator 16 to the guide wire ablation tip 22.
- the ablative guide wire 14 is configured as a mono-polar electrode
- a bi-polar configuration may also be employed.
- the return electrode would be positioned in close proximity to the ablation tip electrode 22.
- a tubular return electrode may be disposed around the tip of catheter 18 proximate its distal end.
- a mono-polar arrangement is preferred, because it allows for a lower profile, ⁇ i.e., no return wire is needed in the catheter 18. It is conceivable, however, to design a bi-polar device wherein the return conductor can be contained within an acceptable profile.
- the catheter body 18 of the centering catheter 12 includes an elongated flexible outer jacket 26 and an elongated flexible inner shaft 28 extending therethrough.
- the outer jacket 26 and inner shaft 28 are preferably composed of a suitable soft and flexible material to minimize the bias around the curvilinear regions of the patient's vasculature.
- the inner shaft 28 is composed of a radio-opaque material, which both facilitates the location of the distal ablation tip 22 within the blood vessel 250 and enhances the collapsing strength of the inner shaft 28.
- a radio-opaque material can be created by compounding heavy metal particles, such as, e.g., 80% (by weight) tungsten added to Marlex 4903 (high density polyethylene), into a thermal plastic.
- the guide wire lumen 20 is formed in the inner shaft 28 and extends therethrough distally terminating at a guide wire exit port 30.
- Centering catheter 12 includes a female Luer fitting 32 formed at the proximal end of the catheter body 18, which mates with an adapter 34 (shown in Fig. 11).
- the centering mechanism 24 of the centering catheter 12 when activated, facilitates the centering of the distal ablation tip 22 within the blood vessel 250, and when deactivated, allows the catheter body 18 to be longitudinally displaced within the blood vessel 250.
- the balloon 36 is composed of a suitable material, such as, e.g., polyamides, polyimides, nylons, and polyether block amide, which is commercially available from, e.g., Atomchel Polymers of Bindsboro, Pennsylvannia under the trade name PEBAX, and is affixed to the distal end of the catheter body 18.
- a suitable material such as, e.g., polyamides, polyimides, nylons, and polyether block amide, which is commercially available from, e.g., Atomchel Polymers of Bindsboro, Pennsylvannia under the trade name PEBAX, and is affixed to the distal end of the catheter body 18.
- the proximal end of the balloon 36 is secured to the distal end of the outer jacket 26, and the distal end of the inflatable balloon 36 is secured to the distal end of the inner shaft 28.
- the balloon 36 is compliant to facilitate the centering of the distal ablation tip 22 within variably sized blood vessels
- a distal side 38 of the balloon 36 includes a shoulder 40 with a substantially vertical profile, i.e., a profile substantially perpendicular to the longitudinal axis of the centering catheter 12.
- the vertical profile of the shoulder 40 allows the distal ablation tip 22 to be located closer to the portion of the balloon 36 contacting the wall of the blood vessel 250 ensuring that the distal ablation tip 22 is centered as it exits the guide wire exit port 30.
- the centering catheter 12 further comprises an inflation lumen 42 formed between outer jacket 26 and sheath 46 of the catheter body 18, i.e., the inflation lumen 42 is annular.
- the inflation lumen 42 terminates proximally at the adapter 34 and distally within the balloon 36.
- Conveyance of a suitable inflation medium, such as, e.g., saline solution, into the inflation lumen 42 expands the balloon 36, thereby activating the centering mechanism 24.
- a suitable inflation medium such as, e.g., saline solution
- the centering catheter 12 further comprises an airless preparation lumen 44 disposed between inner shaft 28 and sheath 46 and terminating distally within the balloon 36.
- the airless preparation lumen 44 provides a convenient means of removing air from the balloon 36 and positively preparing the balloon 36 for subsequent inflation. It should be noted that the airless preparation lumen 44 can be employed in conjunction with the inflation lumen 42 to prepare other types of balloon catheters, such as, e.g., PTCA catheters, and is not to be limited to employment within a centering catheter.
- inflation medium can be conveyed through the airless preparation lumen 44, into the balloon 36, and back out the inflation lumen 42, eliminating the need to bleed inflation medium at the tip of the centering catheter 12 or evacuating air from the balloon 36 prior to inflation thereof.
- the inflation lumen 42 and the airless preparation lumen 44 terminate within the balloon 36 opposite each other ensuring that substantially all of the air is removed from the balloon 36 during the preparation thereof.
- Disposition of the airless preparation lumen 44 within the inflation lumen 42 allows the catheter body 18 to be manufactured with a smaller profile, decreasing the amount of stress of the patient's vasculature as it advances therethrough. Additionally, the independence of the outer jacket 26 and sheath 46 allows the catheter body 18 to be more easily manufactured as compared to standard dual-lumen catheters. This concentric design also provides for a lower profile of catheter body 18.
- the airless preparation lumen 44 is formed between sheath 46 and the inner shaft 28, i.e., the airless preparation lumen 44 is annular.
- the centering catheter 12 comprises an airless preparation lumen 48 formed solely within a flexible elongated tube 50 independent of the inner shaft 28, i.e., the airless preparation lumen 48 is circular.
- the ablative guide wire 14 extends through the guide wire lumen 20 of the inner shaft 28 of the catheter body 18, with the distal ablation tip 22 of the guide wire 14 extending out the guide wire exit port 30 of the guide wire lumen 30 for placement in contact with body tissue.
- the diameter of the guide wire 14 is sized, such that it is compatible for use with Percutaneous Transluminal Coronary Angioplasty (PTCA) and/or Percutaneous Transluminal Angioplasty (PTA) catheters, as well as other diagnostic and therapeutic devices.
- PTCA Percutaneous Transluminal Coronary Angioplasty
- PTA Percutaneous Transluminal Angioplasty
- the guide wire 14 is relatively small, having a diameter of from about 0.004 to 0.030 inches.
- Exemplary diameters are 0.014 inches to provide compatibility with standard PTCA catheters, and 0.009 inches to provide compatibility with atherectomy catheters, such as, e.g., the Rotablator® system.
- the guide wire 14 has an exemplary length consistent with that of a PTCA guide wire, i.e., 300 cm.
- the guide wire 14 comprises an elongate shaft 52 composed of a suitable material, such as, e.g., 3XX series stainless steel, cobalt alloys, nickel titanium alloys, or combinations of tungsten/gold with stainless steel or cobalt alloys, to provide high strength and corrosion resistance.
- the guide wire 14 further includes a layer of electrical insulation 54 formed at the proximal and distal ends of the shaft 52.
- the distal ablation tip 22 is bare of the insulation 54, allowing conveyance of RF energy between the distal ablation tip 22 and the tissue.
- the portion of the shaft 52 between the proximal and distal ends thereof is bare of the insulation 54, since the inner shaft 28 provides electrical insulation to the guide wire 14 when the guide wire 14 is disposed within the guide wire lumen 20.
- a proximal tip of the shaft 52 is bare of the insulation 54, allowing electrical connection to the connector 11 (Fig. 1).
- the insulation 54 along with the inner shaft 28, facilitates the effective delivery of RF power to the distal ablation tip 22 by restricting the dissipation of the RF energy to the distal ablation tip 22.
- the insulation 54 is at least 0.001 inches thick to sustain the level of RF energy that will be conducted through the shaft 52 (generally about 20-30 watts).
- the insulation 54 is composed of suitable bio-compatible material, such as, e.g., polytetrafluoroethylene (PTFE) (available as TEFLON® from E.I. Dupont), polyimide and polyester.
- PTFE polytetrafluoroethylene
- PTFE and polyester can be formed onto the shaft 52 as heat shrink tubes, while polyimide and TEFLON® can be formed onto the shaft 52 as a dip coating or spray coating.
- heat shrink tubing is used as it provides the best control of thickness uniformity and freedom from pin hole like defects.
- an insulation application machine 200 is employed to apply insulation 54 to the shaft 52 using heat shrink tubing.
- the insulation application machine 200 comprises a motorized pull system 202 configured to stretch the heat shrink tubing to a desired thickness.
- the heat shrink tubing is connected to the motorized pull system 202 via a pull string 204.
- the insulation application further includes a hot air gun 206 mounted on a computer controlled traveling stage 208, and is thus configured to longitudinally translate the length of the heat shrink tubing (shown by arrow 207) while heating the same to a desired temperature at the same time.
- the motorized pull system 202 includes a clamp 205, which anchors one end of the heat shrink tubing to the shaft 52 while the heat shrink tubing is being stretched.
- the proximal end of the heat shrink tubing is anchored to one end of the shaft 52, using the clamp 205.
- the heat shrink tubing is then disposed over the shaft 52, the distal end of which is connected to the motorized pull system 202 via the pull string 204.
- the motorized pull system 202 is then operated, stretching the heat shrink tubing to a desired thickness. In this manner, the resulting insulation 54 is thinned, ensuring compatibility between the guide wire 14 and any associated therapeutic catheter.
- the hot air gun 206 and travelling stage 208 is operated to heat the length of the stretched heat shrink tubing, preferably between 650°F and 800°F, thereby adhering the heat shrink tubing to the shaft 52 to form the ablative guide wire 14.
- the catheter body 18 provides insulation to the guide wire 14
- only the distal and proximal ends of the guide wire 14 are insulated with the heat shrink tubing, maximizing the thickness of the shaft 52 and improving the electrical property of the guide wire 14.
- Exemplary insulated lengths of the distal and proximal ends of the guide wire 14 are respectively, 15 and 100 cms.
- the distal end of the guide wire 14 is tapered to provide steerability and flexibility to the guide wire 14.
- the tapered portion of the guide wire 14 includes a combination of alternating cylindrical sections 55 and tapered sections 57.
- the distal end of the guide wire 14 exhibits enough rigidity, such that it can be configured to assume a curvilinear geometry (i.e., shapeable). In this manner, the distal ablation tip 22 can be safely and efficiently translated through a curvilinear region of the vessel 250 during ablation.
- the distal end of the guide wire 14 includes a platinum allow spring to provide the guide wire 14 with radio opaqueness.
- the distal end of the guide wire 14 can include a resilient polymer jacket impregnated with radio-opaque material.
- radio opaqueness can be provided to the guide wire 14 by applying a radio opaque coating, such as, e.g., gold, to the distal end thereof.
- the distal ablation tip 22 of the guide wire 14 includes a non-traumatic structure 56, such as, e.g., a spherically shaped structure (i.e., a ball or half- ball), to minimize tissue trauma, while localizing RF energy conveyed through the guide wire 14 to allow initiation and maintenance of tissue ablation at low RF power levels.
- a non-traumatic structure 56 such as, e.g., a spherically shaped structure (i.e., a ball or half- ball)
- the distal ablation tip 22 includes at least one discontinuous feature 58 associated with the structure 56, such as, e.g., an edge or point, to further facilitate the sparking between the distal ablation tip 22 and the tissue as will be described in further detail below.
- discontinuous feature 58 associated with the structure 56, such as, e.g., an edge or point, to further facilitate the sparking between the distal ablation tip 22 and the tissue as will be described in further detail below.
- various ablation tips 22 will be described with reference to Figs. 6-10.
- Fig. 6 depicts an ablation tip 22(1), which includes a structure 56(1) in the form of a ball.
- the distal ablation tip 22(1) further includes a discontinuous feature 58(1) in the form of a shallow cavity with a circumferential edge disposed on the non-traumatic structure 56(1). In this manner, the distribution of RF energy along the surface of the structure 56(1) is localized along the edge of the discontinuous feature 58(1).
- Fig. 7 depicts an ablation tip 22(2), which includes a structure 56(2) in the form of a ball.
- the distal ablation tip 22(2) further includes a discontinuous feature 58(2) in the form of a point disposed on the non-traumatic structure 56(2). In this manner, the distribution of RF energy along the surface of the structure 56(2) is localized at the point of the discontinuous feature 58(2).
- Fig. 8 depicts an ablation tip 22(3), which includes a hollow bell-shaped structure
- the distal ablation tip 22(3) further includes a discontinuous feature in the form of a point disposed within the structure 56(3).
- the structure 56(3) is electrically insulated.
- Fig. 9 depicts an ablation tip 22(4), which includes a structure 56(4) in the form of a ball.
- the distal ablation tip 22(4) further includes a plurality of discontinuous features 58(4) in the form of microscopic roughened points or edges, which is applied to the outer surface of the structure 56(4) by suitable means, such as, e.g., etching, film deposition, or grit blasting.
- suitable means such as, e.g., etching, film deposition, or grit blasting.
- Fig. 10 depicts an ablation tip 22(5), which includes a structure 56(5) in the form of a ball.
- the distal ablation tip 22(5) further includes a plurality of discontinuous features 58(5) in the form of microscopic non-conducting particles disposed on the outer surface of the structure 56(5).
- the dispersion of the non-conducting particles serves to reduce the effective cross-sectional area of the structure 56(5). In this manner, the distribution of RF energy along the structure 56(5) is localized between the non-conducting particles.
- Fig. 11 particularly shows the adapter 34, which mates with the female Luer fitting 32 of the catheter 12.
- the adapter 34 includes a body 60 with a male Luer fitting 62 on a first end and a gland nut 64 on a second end.
- the guide wire 14 passes through both male Luer fitting 62 and the gland nut 64. Feeding is continued until the female Luer fitting 32 on the catheter 12 is engaged with the male Luer fitting 62 of the adapter 34.
- the gland nut 64 on the adapter 34 is tightened to secure the guide wire 14 in place relative to the catheter 12 and to prevent loss of fluid at the point where the guide wire 14 exits the adapter 34. Relative positioning of the distal ablation tip 22 of the guide wire 14 to the guide wire exit port 30 of the catheter body 18 is accomplished by loosening the gland nut 64.
- the adapter 34 further includes an inflation port 66 and a preparation port 68, which are respectively in fluid communication with the inflation lumen 42 and the airless preparation lumen 44.
- the inflation port 66 provides a means for conveying an inflation medium into the inflation lumen 38 during expansion of the balloon 36
- the preparation port 68 provides a means for removing air from the balloon 36.
- the RF generator 16 includes a source of energy 70, which is approximately twenty to thirty watts in a preferred embodiment.
- the source of energy 70 is selectively coupled via the footswitch 74 to a primary winding 171 of an isolating transformer 172.
- transfer of energy from the primary winding 171 to the transformer core 175 is driven by an NMOS transistor switch 174.
- the NMOS switch 174 is cyclically driven ON and OFF by an oscillator circuit 176, preferably at a frequency of 500 KHz or higher to avoid interference with the normal electrical stimulation of the heart.
- the respective primary and secondary transformer windings 171 and 173 are configured in a flyback mode.
- NMOS transistor 174 When the NMOS transistor 174 is ON, cu ⁇ ent passes through the primary winding 171 and energy is stored in the transformer core 175. When the NMOS transistor is turned OFF, energy stored in the core 175 is released in the form oof current through the secondary winding 173. In particular, when NMOS transistor 174 turns OFF, the voltage at the NMOS drain increases significantly. This is because the voltage across the transformer 172 is proportionate to the time-derivative of the current passing through the primary winding 173. Since the current is forced to cease when the NMOS transistor 174 turns OFF, (but does not in fact immediately cease), the corresponding time-derivative has a very high value at this point. This, in turn, causes the voltage across the transformer core 175 to increase substantially, resulting in a voltage "spike" through the secondary each time the NMOS transistor 174 is turned OFF at the beginning of each new energy transfer cycle, or pulse.
- the output voltage signal 190 through the secondary winding 173 of the transformer 172 is shown in Fig 12 A, as a series of discrete pulses, each pulse having a respective voltage spike 192 at its leading edge.
- the output signal pulses have voltage spikes 192 of approximately five to ten times higher in amplitude than the RMS output voltage of the signal 190.
- the output voltage signal 190 is preferably supplied for a discrete duration, e.g., 1-2 seconds, each time the foot switch 74 is activated.
- any number of power supply topologies may be used to achieve a voltage output signal having the general form of signal 190 without departing from the invention. What is important is that the discrete pulses have the momentary peak amplitude to provide a high sparking potential at the guide wire ablation tip 22, without unduly increasing the overall RMS voltage of the signal. Alternately, the voltage spikes 192 could be generated only when needed to initiate the spark erosion process, with the output signal otherwise being an attenuated waveform, such as squared cosine.
- a pair of capacitors 178 and 180 are provided in series with the circuit formed through the patient by the respective ablation and patient return electrodes 22 and 72 on the output side of the transformer 172.
- the capacitors 178 and 180 are sized to set the generator system output impedance "seen" at the guide wire ablation tip 22.
- the capacitors 178 and 180 also serve to limit the maximum voltage delivered to the patient tissue, according to the relationship: ' /tissue — ' source ( ⁇ tissue ' ( ⁇ tissue ' ⁇ c where Z t i SS ue is the load impedance of the tissue or blood contacting the ablation electrode and Z c is total impedance value of the series capacitors 178 and 180.
- capacitors 178 and 180 are sized to set the system output impedance to a level greater than the load impedance of blood and healthy vessel wall tissue in order to reduce the power output when the ablation electrode 22 is not in contact with the (high impedance) occlusive matter. In particular, it is desirable to achieve a high current density at the distal tip of the ablation electrode 22 for initiating the spark erosion process, without requiring maximum output power from the generator 16.
- Figs. 12B-D illustrate the respective relationships between the output cu ⁇ ent, voltage and power, respectively, of the generator versus the load impedance "seen" at the guide wire ablation electrode 22.
- the output voltage is directly proportional to the load impedance, i.e., the higher the load impedance, the greater the voltage potential.
- the output cu ⁇ ent is inversely proportional to the load impedance, i.e., as the load impedance increases, the output current decreases.
- the output power of the generator 16 is dependent upon the relative impedance match been the electrode tip 22 and the load impedance.
- Fig 12D shows the relationship between output power of the generator 16 versus the load impedance seen at the electrode tip 22 for a system impedance (i.e., as set by capacitors 178 and 180) of approximately 600 ohms.
- the generator is activated with the electrode tip in contact with blood (150-200 ohm/cm).
- blood 150-200 ohm/cm.
- the impedance is low, the voltage potential is also low enough that the spark erosion process is not initiated, although a relatively high cu ⁇ ent due to the impedance mismatch is contributing to a small amount of ohmic heating at the electrode tip.
- tissue or blood necrosis from the ohmic heating from the current can be minimized.
- the benefits of reducing power output when the electrode tip 22 is in contact with blood or healthy vessel wall tissue in terms of reduced tissue damage and/or potential for unwanted ablation or cha ⁇ ing are believe to far exceed the possible damage caused by ohmic heating at low load impedance levels.
- the output power is maximized with the electrode in "close contact" with occlusive tissue resulting in a load impedance of approximately 600 ohm/cm, i.e., substantially matching the generator system impedance.
- the generator voltage, impedance and electrode geometry are selected such that the spark erosion process will be initiated at a load impedance greater than blood and/or healthy vessel tissue - i.e., near point B in FIG. 12D.
- the load impedance will increase substantially — e.g., to a range of 1800-2000 ohm/cm, — or decrease substantially, — e.g., least than 50 ohm/cm, — depending upon the ionization charge density of the plasma state and the relative position of the electrode tip 22. If the impedance increases, the sparking voltage potential will be maintained, even though the power output will decrease (i.e., past point C in Fig. 12D). If the impedance drops, the voltage potential and power output will also drop (e.g., to the left of point A in Fig. 12D), although the plasma state will be maintained at a much lower voltage potential than is required for its initiation.
- an alternate prefe ⁇ ed embodiment of the recanalization system 100 includes a variable impedance means 194 coupled at the output of the RF generator 16, i.e., in addition to, or in lieu of, capacitors 178 and 180.
- the variable impedance means 194 is coupled to an impedance selection means 196, which in turn is coupled to an input means 198.
- the input means 224 provides an attending surgeon or other user of the recanalization system to enter information pertaining to the specific procedure being performed, such as, e.g., the type or model number of centering catheter 12 and/or ablation guide wire 14, the geometric design or surface area of the ablation electrode 22, the weight of the patient, the desired voltage, etc.
- the variable impedance means 194 may include active or passive components such as capacitors, inductors, resistors, and transistors or any combination thereof.
- the variable impedance means 194 is comprised of a network of capacitors and solid state switching devices.
- the impedance of variable impedance means may be varied by switching capacitors into, or out of, the network.
- the actual impedance value of variable impedance means 194 is selected by the impedance selection means 196.
- the impedance selection means 196 controls the state of the respective solid state switches within the variable impedance means 194.
- impedance selection means 196 is based at least in part on the geometry of the particular ablation electrode 22 being used for the procedure.
- the impedance selection means 196 may also include stored information useful for selecting an appropriate impedance value, such as impedance values appropriate for each model of guide wire and/or voltage level. Other factors may be used in determining appropriate impedance values without deviating from the spirit or scope of the present invention. In any case, the impedance value of variable impedance means 196 is preferably selected so that maximum voltage power transfer occurs when the ablation electrode 22 is in contact with occlusive lesion tissue.
- the return electrode 72 is attached to the patient (not shown) using conductive jelly to ensure positive and dispersive electrical contact with the patient.
- the guide wire 14 is routed through the vasculature until the distal ablation tip 22 is disposed just proximal to the total occlusion 252 of the blood vessel 250 (Fig. 13).
- the centering catheter 12 With the centering mechanism 24 deactivated, i.e., the balloon 36 deflated, the centering catheter 12 is advanced over the guide wire 14 until the centering mechanism 24 is disposed adjacent the total occlusion 252 (Fig. 14).
- the centering mechanism 24 is positively prepared, i.e., inflation medium or contrast agent is conveyed via the preparation port 68 through the airless preparation lumen 44, into the balloon 36, out through the inflation lumen 42 and inflation port 66, thereby substantially removing all of the air from the balloon 36.
- the radiopacity of the balloon 36 is improved. That is, air in the balloon 36 will not typically appear under standard fluoroscopy procedures, making the balloon 36 difficult to locate.
- removing air from the balloon 36 and completely filling the balloon 36 with contrast agent allows the balloon 36 to be more easily located.
- the air can be removed from the balloon 36 by conveying the inflation medium or contrast agent into the inflation port 66 and out through the preparation port 68. It should be noted that rather than positively preparing the centering mechanism 24 while placed within the vasculature of the patient, it may be determined that it is preferable to positively prepare the centering mechanism 24 prior to placement within the vasculature of the patient. It should also be noted that the centering mechanism 24 can be positively prepared using means other than the combination of the airless preparation lumen 44 and inflation lumen 42.
- the centering mechanism 24 is then activated, i.e., the balloon 36 is inflated by sealing the preparation port 68 and conveying an inflation medium into the inflation port 66 of the adapter 32 until the balloon 36 expands into secure contact with the blood vessel 250 (Fig. 15).
- the sheath 46 is preferably manufactured, such that it collapses around the inner shaft 28 subsequent to sealing the preparation port 68.
- the centering mechanism 24 maintains the guide wire 14 along a centerline 256 of the blood vessel 250, such that the distal ablation tip 22 is substantially centered within the blood vessel 250 as it contacts the occlusion 252.
- the footswitch 74 shown in Fig. 1) is then depressed to energize the distal ablation tip 22.
- Moderate pressure is applied to the guide wire 14 in the distal direction to cause the distal ablation tip 22 to advance through the center of the occlusion 252 when RF energy is applied (Fig. 16) and creating a channel 258 within the center of the occlusion 252.
- the centering mechanism 24 is deactivated, i.e., the balloon 36 is deflated by opening the preparation port 68 and removing inflation medium from the inflation port 66.
- the centering catheter 12 is then removed, and the guide wire 14 is used to guide any of a variety of therapeutic devices for subsequent treatment of the occlusion or related disorders, including, but not limited to, PTCA, PTA or percutaneous transluminal rotary ablation catheters.
- a PTCA catheter 272 which employs a dilation balloon 274, can be introduced over the guide wire 14 and advanced until the dilation balloon 274 is disposed within the channel 258 of the occlusion B (Fig. 17).
- the dilation balloon B is then inflated to dilate the occlusion 252 (Fig. 18).
- the centering catheter 12 can employ various other centering mechanisms to facilitate the therapy of totally occluded blood vessels.
- Fig. 19 depicts a centering mechanism 100, which provides a stable yet flexible platform, allowing the distal ablation tip 22 to be centered within a curvilinear region of a blood vessel.
- the centering mechanism 100 particularly includes an inflatable/deflatable segmented balloon 102, which forms relatively short first and second segments 104 and 106 when inflated, preferably less than 8 mm.
- the segmented balloon 102 is composed of a material and is manufactured in a similar manner as that described above with respect to the balloon 36.
- the centering mechanism 100 further includes a restriction band 108, which is disposed around the segmented balloon 102 to create the respective segments 104 and 106 when inflated.
- a distal side 110 of the first segment 104 includes a shoulder 112 with a substantially flat profile to ensure that the distal ablation tip 22 is centered as it exits the guide wire exit port 30.
- the segmented balloon 102 provides both flexibility and stability to the distal end of the centering catheter 12, allowing the catheter body 18 to conform to a curvilinear region 262 of the blood vessel 250 (shown in Fig. 22) when the centering mechanism 100 is activated.
- the centering mechanism 100 facilitates the centering of the distal ablation tip 22 within a curvilinear region 262, as well as the rectilinear region 254, of the blood vessel 250.
- Flexibility of the centering catheter 12 is provided by the segmented nature of the centering mechanism 100 and the relative short longitudinal length of each of the segments 104 and 106, allowing the centering catheter 12 to be biased by the curvilinear geometry of the blood vessel 250 rather than by the centering mechanism 100.
- the gap between the respective segments 104 and 106 of the segmented balloon 102 can be varied to adjust the flexibility of the centering mechanism 100. Preferably, however, the gap is less then 4 mm to maintain stability along the length of the centering mechanism 100.
- the overall longitudinal length of the centering mechanism 100 provides stability to the distal end of the centering catheter 12 in that it prevents the catheter body 18 from pitching, which would normally result from the use of a single short balloon in a curvilinear vessel.
- the segmented balloon 102 can comprise more than two segments to further enhance the stability of the centering mechanism 100.
- the segmented balloon 102 can be formed by stretching a single extruded piece of material over a shaped mandrel to create respective pre-formed segments 104 and 106. When inflated, the segmented balloon 102 naturally forms the respective segments 104 and 106, such that an external force, such as by restricting with bands, is not required.
- an the segmented balloon 102 is composed of two pieces of extruded material, which are bonded to each other via a lap-joint 108 to form respective segments 104 and 106.
- the total thickness of the material forming the lap-joint 108 is equal to the thickness of the material forming the remaining portions of the segmented balloon 102, such that the segmented balloon 102 has a uniform thickness.
- the centering mechanism 100 when activated ensures that the guide wire 14 (shown in phantom) is maintained along the centerline 264 of the blood vessel 250, such that the distal ablation tip 22 is substantially centered within the blood vessel 250 as it contacts the occlusion 260.
- the distal end of the guide wire 14 is preformed to conform to the curvilinear geometry of the curvilinear region 262 of the blood vessel 250, such that the guide wire 14 is maintained along the centerline 264 of the blood vessel 250 as the guide wire 14 traverses the occlusion 260.
- the occlusion 260 is traversed over a plurality of ablation procedures and removed over a plurality of therapeutic procedures.
- the generator 16 is activated and the distal ablation tip 22 is partially advanced through the occlusion 260 to create a partial channel 266 (Fig. 24).
- the centering catheter 12 is removed and the therapeutic device, such as, e.g., the PTCA catheter 272 shown in Figs. 17-18 is advanced up the guide wire 14 until the dilation balloon 274 is disposed within the partial channel 71 (Shown in Fig. 25).
- the dilation balloon 274 is inflated to dilate a portion of the occlusion 252 (Shown in Fig. 26).
- the PTCA catheter 272 is then removed and the centering catheter 12 is advanced up the guide wire 14 and the centering mechanism is activated (shown in Fig. 27). This process is repeated until the occlusion 260 has been totally recanalized and treated.
- Fig. 28 depicts another centering mechanism 110, which allows the distal ablation tip 22 to be centered within the curvilinear region 262 of the blood vessel 250.
- the centering mechanism 110 particularly includes a relatively short inflatable/deflatable balloon 112 distally formed on the catheter body 18.
- the balloon 112 is composed of a material and manufactured in a similar manner as that described above with respect to the balloon 36.
- the centering mechanism 110 further includes a resilient support 114 disposed in the catheter body 18 proximal to the balloon 112.
- the resilient support 114 is pre-formed into a complex geometry, and is composed of a resilient material, such as, e.g., Nickel Titanium, thereby imparting the same complex geometry onto the portion of the catheter body 18 in which it is disposed.
- the complex geometry of the resilient support 114, and the portion of the catheter body 18 in which it is disposed, is helical.
- the resilient support 114 can be pre-formed into other complex geometries, however, such as, e.g., a bi-planar wave
- the resilient support 114 includes alternating sections of waves that lie in orthogonal planes as depicted in Fig. 29.
- the complex geometry allows the portion of the catheter body 18 proximal to the balloon 112 to conform to the vessel 250. In this manner, as depicted in Fig. 30, both flexibility and stability is provided to the centering catheter 12, thereby facilitating proper centering of the distal ablation tip 22 within the curvilinear region 262 of the blood vessel
- Fig. 31 depicts an alternative prefe ⁇ ed embodiment of a centering catheter 120, which can be employed in the vessel recanalization system 10.
- the centering catheter 120 includes a catheter body 122 with co-extruded lumens.
- the catheter body is co-extruded.
- 122 includes a flexible elongate tubular member 124 in which there is extruded a guide wire lumen 126 for disposition of the guide wire 14.
- the centering catheter 120 further includes a centering mechanism 130, which facilitates the centering of the distal ablation tip 22 within the totally occluded rectilinear vessel 250 (shown in Fig. 13).
- the centering mechanism 130 comprises an inflatable/deflatable balloon 132, much like the balloon 36 described above.
- the centering catheter 120 further includes inflation lumens 134, which are coextruded with the guide wire lumen 126 in the tubular member 124, and inflation ports 136, which traverse the wall of the tubular member 124 to provide fluid communication between the inflation lumens 134 and the balloon 132. Operation of the centering catheter 120 is similar to that of the centering catheter 12 described above.
- the centering catheter 120 can employ various other centering mechanisms to facilitate the therapy of totally occluded blood vessels.
- Fig. 32 depicts a centering mechanism 140 that can be employed by the centering catheter 120 to facilitate the centering of the distal ablation tip 22 within the curvilinear region 262 of the blood vessel
- the centering mechanism 140 comprises a segmented inflatable/deflatable balloon 142 with respective segments 144 and 146, much like the balloon 102 described above.
- the balloon 142 is secured to the distal end of the tubular member 124.
- the centering catheter 120 further includes inflation lumens 148, which are co-extruded with the guide wire lumen 126 in the tubular member 124, and inflation ports 150, which traverse the wall of the tubular member 124 to provide fluid communication between the inflation lumens 148 and the balloon 142. Operation of the centering catheter 120 is similar to that of the centering catheter 12 described above.
- Fig. 33 depicts a centering mechanism 160 that can be employed by the centering catheter 120 to facilitate the centering of the distal ablation tip 22 within the curvilinear region 262 of the blood vessel 250 (shown in Fig. 22).
- the centering mechanism 160 comprises a pair of pre-shaped wires 162, each of which includes a wire shaft 164 and a distally located centering ring 166.
- the centering rings 166 are composed of a pre-shaped material, such as, e.g., Nickel
- centering rings 166 form circular rings, which are orthogonal to the shafts of the wires, in the absence of external force.
- the centering catheter 120 further includes a pair of pull wire lumens 168, which are co-extruded with the guide wire lumen 126 in the tubular member 124.
- the pair of pre-shaped wires 162 are slidingly disposed within the respective pull wire lumens 168.
- the pull wire lumens 168 distally terminate into respective pull wire exit ports 170.
- proximal longitudinal displacement of the preshaped wires 162 through the respective wire lumens 168 causes the distal ends of the pre- shaped wires 162 (shown in phantom) to retract into the respective pull wire exit ports 170, storing the centering rings 166 within the respective wire lumens 168 and deactivating the centering mechanism 160.
- pre-shaped wires 162 and pull wire lumens 168 can be employed in the centering mechanism 160 to provide further stability to the centering catheter 120.
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/256,977 | 1999-02-24 | ||
US09/256,977 US6210408B1 (en) | 1999-02-24 | 1999-02-24 | Guide wire system for RF recanalization of vascular blockages |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2000050115A2 WO2000050115A2 (en) | 2000-08-31 |
WO2000050115A3 WO2000050115A3 (en) | 2000-12-14 |
WO2000050115A9 true WO2000050115A9 (en) | 2002-06-20 |
Family
ID=22974384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/004475 WO2000050115A2 (en) | 1999-02-24 | 2000-02-22 | Guide wire system for rf recanalization of vascular blockages |
Country Status (2)
Country | Link |
---|---|
US (2) | US6210408B1 (en) |
WO (1) | WO2000050115A2 (en) |
Families Citing this family (355)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK124690D0 (en) | 1990-05-18 | 1990-05-18 | Henning Rud Andersen | FAT PROTECTION FOR IMPLEMENTATION IN THE BODY FOR REPLACEMENT OF NATURAL FLEET AND CATS FOR USE IN IMPLEMENTING A SUCH FAT PROTECTION |
US6006134A (en) | 1998-04-30 | 1999-12-21 | Medtronic, Inc. | Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers |
EP0850607A1 (en) | 1996-12-31 | 1998-07-01 | Cordis Corporation | Valve prosthesis for implantation in body channels |
US8506519B2 (en) | 1999-02-16 | 2013-08-13 | Flowcardia, Inc. | Pre-shaped therapeutic catheter |
US6855123B2 (en) | 2002-08-02 | 2005-02-15 | Flow Cardia, Inc. | Therapeutic ultrasound system |
US6702811B2 (en) | 1999-04-05 | 2004-03-09 | Medtronic, Inc. | Ablation catheter assembly with radially decreasing helix and method of use |
DE19930266A1 (en) * | 1999-06-25 | 2000-12-28 | Biotronik Mess & Therapieg | catheter |
US7018406B2 (en) | 1999-11-17 | 2006-03-28 | Corevalve Sa | Prosthetic valve for transluminal delivery |
US8579966B2 (en) | 1999-11-17 | 2013-11-12 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US8016877B2 (en) | 1999-11-17 | 2011-09-13 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US8241274B2 (en) | 2000-01-19 | 2012-08-14 | Medtronic, Inc. | Method for guiding a medical device |
US7749245B2 (en) | 2000-01-27 | 2010-07-06 | Medtronic, Inc. | Cardiac valve procedure methods and devices |
US6602250B2 (en) * | 2000-01-31 | 2003-08-05 | Wilson-Cook Medical Incorporated | Echogenic wire knife |
US6454799B1 (en) | 2000-04-06 | 2002-09-24 | Edwards Lifesciences Corporation | Minimally-invasive heart valves and methods of use |
WO2002005888A1 (en) | 2000-06-30 | 2002-01-24 | Viacor Incorporated | Intravascular filter with debris entrapment mechanism |
US6656174B1 (en) * | 2000-07-20 | 2003-12-02 | Scimed Life Systems, Inc. | Devices and methods for creating lesions in blood vessels without obstructing blood flow |
US7556646B2 (en) | 2001-09-13 | 2009-07-07 | Edwards Lifesciences Corporation | Methods and apparatuses for deploying minimally-invasive heart valves |
US6733525B2 (en) | 2001-03-23 | 2004-05-11 | Edwards Lifesciences Corporation | Rolled minimally-invasive heart valves and methods of use |
US7020531B1 (en) * | 2001-05-01 | 2006-03-28 | Intrapace, Inc. | Gastric device and suction assisted method for implanting a device on a stomach wall |
US20080065169A1 (en) * | 2001-05-01 | 2008-03-13 | Intrapace, Inc. | Endoscopic Instrument for Engaging a Device |
US7702394B2 (en) | 2001-05-01 | 2010-04-20 | Intrapace, Inc. | Responsive gastric stimulator |
US7544206B2 (en) | 2001-06-29 | 2009-06-09 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
US8623077B2 (en) | 2001-06-29 | 2014-01-07 | Medtronic, Inc. | Apparatus for replacing a cardiac valve |
US8771302B2 (en) | 2001-06-29 | 2014-07-08 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
FR2826863B1 (en) | 2001-07-04 | 2003-09-26 | Jacques Seguin | ASSEMBLY FOR PLACING A PROSTHETIC VALVE IN A BODY CONDUIT |
FR2828091B1 (en) | 2001-07-31 | 2003-11-21 | Seguin Jacques | ASSEMBLY ALLOWING THE PLACEMENT OF A PROTHETIC VALVE IN A BODY DUCT |
US7097659B2 (en) | 2001-09-07 | 2006-08-29 | Medtronic, Inc. | Fixation band for affixing a prosthetic heart valve to tissue |
US6893460B2 (en) | 2001-10-11 | 2005-05-17 | Percutaneous Valve Technologies Inc. | Implantable prosthetic valve |
US7037313B2 (en) * | 2002-03-19 | 2006-05-02 | Fibrex, Llc | Apparatus for stripping fibrin from a catheter |
US20140018880A1 (en) | 2002-04-08 | 2014-01-16 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for monopolar renal neuromodulation |
US7653438B2 (en) | 2002-04-08 | 2010-01-26 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US8774913B2 (en) | 2002-04-08 | 2014-07-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for intravasculary-induced neuromodulation |
US8177790B2 (en) * | 2002-04-20 | 2012-05-15 | Friedhelm Brassel | Medical retriever |
US20040147828A1 (en) * | 2002-04-22 | 2004-07-29 | Gibson Charles A. | Telescoping tip electrode catheter |
US8043286B2 (en) | 2002-05-03 | 2011-10-25 | The Board Of Trustees Of The Leland Stanford Junior University | Method and apparatus for plasma-mediated thermo-electrical ablation |
US6780178B2 (en) * | 2002-05-03 | 2004-08-24 | The Board Of Trustees Of The Leland Stanford Junior University | Method and apparatus for plasma-mediated thermo-electrical ablation |
US7840261B2 (en) * | 2002-06-05 | 2010-11-23 | Biocardia, Inc. | Catheter systems and methods for placing bi-ventricular pacing leads |
US9439714B2 (en) * | 2003-04-29 | 2016-09-13 | Atricure, Inc. | Vacuum coagulation probes |
US7063698B2 (en) | 2002-06-14 | 2006-06-20 | Ncontact Surgical, Inc. | Vacuum coagulation probes |
US8235990B2 (en) | 2002-06-14 | 2012-08-07 | Ncontact Surgical, Inc. | Vacuum coagulation probes |
US7572257B2 (en) * | 2002-06-14 | 2009-08-11 | Ncontact Surgical, Inc. | Vacuum coagulation and dissection probes |
US6893442B2 (en) | 2002-06-14 | 2005-05-17 | Ablatrics, Inc. | Vacuum coagulation probe for atrial fibrillation treatment |
US7166120B2 (en) * | 2002-07-12 | 2007-01-23 | Ev3 Inc. | Catheter with occluding cuff |
US20040024425A1 (en) * | 2002-07-31 | 2004-02-05 | Worley Seth J. | Method and apparatus for using a cardiac stimulating, sensing and guidewire combination |
US9955994B2 (en) | 2002-08-02 | 2018-05-01 | Flowcardia, Inc. | Ultrasound catheter having protective feature against breakage |
US8133236B2 (en) | 2006-11-07 | 2012-03-13 | Flowcardia, Inc. | Ultrasound catheter having protective feature against breakage |
US7335180B2 (en) | 2003-11-24 | 2008-02-26 | Flowcardia, Inc. | Steerable ultrasound catheter |
US7220233B2 (en) | 2003-04-08 | 2007-05-22 | Flowcardia, Inc. | Ultrasound catheter devices and methods |
US7604608B2 (en) * | 2003-01-14 | 2009-10-20 | Flowcardia, Inc. | Ultrasound catheter and methods for making and using same |
US6942677B2 (en) | 2003-02-26 | 2005-09-13 | Flowcardia, Inc. | Ultrasound catheter apparatus |
US7137963B2 (en) | 2002-08-26 | 2006-11-21 | Flowcardia, Inc. | Ultrasound catheter for disrupting blood vessel obstructions |
US20040102719A1 (en) * | 2002-11-22 | 2004-05-27 | Velocimed, L.L.C. | Guide wire control catheters for crossing occlusions and related methods of use |
US7828796B2 (en) * | 2003-01-21 | 2010-11-09 | Baylis Medical Company Inc. | Method for creating a channel through an occlusion and apparatus therefor |
US10493259B2 (en) * | 2003-01-21 | 2019-12-03 | Baylis Medical Company Inc. | Medical apparatus for fluid communication |
US8092450B2 (en) * | 2003-01-21 | 2012-01-10 | Baylis Medical Company Inc. | Magnetically guidable energy delivery apparatus and method of using same |
US8192425B2 (en) * | 2006-09-29 | 2012-06-05 | Baylis Medical Company Inc. | Radiofrequency perforation apparatus |
US7736361B2 (en) * | 2003-02-14 | 2010-06-15 | The Board Of Trustees Of The Leland Stamford Junior University | Electrosurgical system with uniformly enhanced electric field and minimal collateral damage |
US10172538B2 (en) | 2003-02-21 | 2019-01-08 | 3Dt Holdings, Llc | Body lumen junction localization |
US8078274B2 (en) | 2003-02-21 | 2011-12-13 | Dtherapeutics, Llc | Device, system and method for measuring cross-sectional areas in luminal organs |
US10413211B2 (en) | 2003-02-21 | 2019-09-17 | 3Dt Holdings, Llc | Systems, devices, and methods for mapping organ profiles |
US20080269846A1 (en) * | 2003-03-14 | 2008-10-30 | Light Sciences Oncology, Inc. | Device for treatment of blood vessels using light |
US7252677B2 (en) * | 2003-03-14 | 2007-08-07 | Light Sciences Oncology, Inc. | Light generating device to intravascular use |
CN2885311Y (en) | 2006-01-18 | 2007-04-04 | 郑成福 | Via urethra prostate therapeutic equipment using photodynamic therapy |
US10376711B2 (en) * | 2003-03-14 | 2019-08-13 | Light Sciences Oncology Inc. | Light generating guide wire for intravascular use |
US7399315B2 (en) | 2003-03-18 | 2008-07-15 | Edwards Lifescience Corporation | Minimally-invasive heart valve with cusp positioners |
EP1648280A4 (en) * | 2003-06-18 | 2007-08-15 | Univ Leland Stanford Junior | Electro-adhesive tissue manipulator |
ATE548079T1 (en) * | 2003-07-09 | 2012-03-15 | Light Sciences Oncology Inc | DEVICE FOR DISTAL PROTECTION AND TREATMENT OF BLOOD VESSELS |
US7763012B2 (en) * | 2003-09-02 | 2010-07-27 | St. Jude Medical, Cardiology Division, Inc. | Devices and methods for crossing a chronic total occlusion |
US20140039484A1 (en) * | 2003-09-19 | 2014-02-06 | Baylis Medical Company Inc. | Methods for creating a channel through an occlusion within a body vessel |
US7758510B2 (en) | 2003-09-19 | 2010-07-20 | Flowcardia, Inc. | Connector for securing ultrasound catheter to transducer |
US20050075725A1 (en) | 2003-10-02 | 2005-04-07 | Rowe Stanton J. | Implantable prosthetic valve with non-laminar flow |
US9579194B2 (en) | 2003-10-06 | 2017-02-28 | Medtronic ATS Medical, Inc. | Anchoring structure with concave landing zone |
JP4422472B2 (en) * | 2003-12-19 | 2010-02-24 | オリンパス株式会社 | Submucosa peeling treatment device and system |
WO2005065563A1 (en) * | 2003-12-31 | 2005-07-21 | Biosense Webster, Inc | Circumferential ablation device assembly with an expandable member |
ITTO20040135A1 (en) | 2004-03-03 | 2004-06-03 | Sorin Biomedica Cardio Spa | CARDIAC VALVE PROSTHESIS |
CN101052359A (en) | 2004-04-23 | 2007-10-10 | 3F医疗有限公司 | Implantable prosthetic valve |
US7122034B2 (en) * | 2004-05-27 | 2006-10-17 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Curved ablation catheter |
US7540852B2 (en) | 2004-08-26 | 2009-06-02 | Flowcardia, Inc. | Ultrasound catheter devices and methods |
DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
US8221343B2 (en) | 2005-01-20 | 2012-07-17 | Flowcardia, Inc. | Vibrational catheter devices and methods for making same |
ITTO20050074A1 (en) | 2005-02-10 | 2006-08-11 | Sorin Biomedica Cardio Srl | CARDIAC VALVE PROSTHESIS |
US7998164B2 (en) * | 2005-03-11 | 2011-08-16 | Boston Scientific Scimed, Inc. | Intravascular filter with centering member |
US7914569B2 (en) | 2005-05-13 | 2011-03-29 | Medtronics Corevalve Llc | Heart valve prosthesis and methods of manufacture and use |
US7780723B2 (en) | 2005-06-13 | 2010-08-24 | Edwards Lifesciences Corporation | Heart valve delivery system |
US20070078510A1 (en) | 2005-09-26 | 2007-04-05 | Ryan Timothy R | Prosthetic cardiac and venous valves |
US20070239011A1 (en) * | 2006-01-13 | 2007-10-11 | Mirabilis Medica, Inc. | Apparatus for delivering high intensity focused ultrasound energy to a treatment site internal to a patient's body |
US20070173798A1 (en) * | 2006-01-23 | 2007-07-26 | Adams Mark L | Minimally invasive methods for thermal treatment |
US8075615B2 (en) | 2006-03-28 | 2011-12-13 | Medtronic, Inc. | Prosthetic cardiac valve formed from pericardium material and methods of making same |
US9282984B2 (en) * | 2006-04-05 | 2016-03-15 | Flowcardia, Inc. | Therapeutic ultrasound system |
US20070239254A1 (en) * | 2006-04-07 | 2007-10-11 | Chris Chia | System for percutaneous delivery and removal of a prosthetic valve |
CA2649119A1 (en) * | 2006-04-13 | 2007-12-13 | Mirabilis Medica, Inc. | Methods and apparatus for the treatment of menometrorrhagia, endometrial pathology, and cervical neoplasia using high intensity focused ultrasound energy |
US20070255270A1 (en) * | 2006-04-27 | 2007-11-01 | Medtronic Vascular, Inc. | Intraluminal guidance system using bioelectric impedance |
US20070255303A1 (en) * | 2006-05-01 | 2007-11-01 | Ethicon Endo-Surgery, Inc. | Integrated Guidewire Needle Knife Device |
US9408607B2 (en) | 2009-07-02 | 2016-08-09 | Edwards Lifesciences Cardiaq Llc | Surgical implant devices and methods for their manufacture and use |
US9585743B2 (en) | 2006-07-31 | 2017-03-07 | Edwards Lifesciences Cardiaq Llc | Surgical implant devices and methods for their manufacture and use |
AU2007281553B2 (en) | 2006-07-31 | 2013-09-19 | Edwards Lifesciences Cardiaq Llc | Sealable endovascular implants and methods for their use |
WO2008021321A2 (en) * | 2006-08-17 | 2008-02-21 | Rjf Holdings Iv, Inc | Method and apparatus for plasma incision of cardiovascular tissue |
US8414643B2 (en) | 2006-09-19 | 2013-04-09 | Medtronic Ventor Technologies Ltd. | Sinus-engaging valve fixation member |
US11304800B2 (en) | 2006-09-19 | 2022-04-19 | Medtronic Ventor Technologies Ltd. | Sinus-engaging valve fixation member |
US8834564B2 (en) | 2006-09-19 | 2014-09-16 | Medtronic, Inc. | Sinus-engaging valve fixation member |
US8048071B2 (en) * | 2006-09-29 | 2011-11-01 | Baylis Medical Company Inc | Method for creating a channel through a foreign material |
US20210121227A1 (en) | 2006-09-29 | 2021-04-29 | Baylis Medical Company Inc. | Connector system for electrosurgical device |
US8623005B2 (en) * | 2007-10-01 | 2014-01-07 | Baylis Medical Company Inc. | Stent graft fenestration |
US11666377B2 (en) | 2006-09-29 | 2023-06-06 | Boston Scientific Medical Device Limited | Electrosurgical device |
US11331121B2 (en) * | 2006-09-29 | 2022-05-17 | Baylis Medical Company Inc. | Transseptal needle |
US9101375B2 (en) * | 2006-09-29 | 2015-08-11 | Baylis Medical Company Inc. | Fenestration through foreign material |
EP2083901B1 (en) | 2006-10-16 | 2017-12-27 | Medtronic Ventor Technologies Ltd. | Transapical delivery system with ventriculo-arterial overflow bypass |
CA2668407A1 (en) | 2006-11-02 | 2008-05-15 | Peak Surgical, Inc. | Electric plasma-mediated cutting and coagulation of tissue and surgical apparatus |
US8246643B2 (en) * | 2006-11-07 | 2012-08-21 | Flowcardia, Inc. | Ultrasound catheter having improved distal end |
EP2086441A4 (en) * | 2006-11-09 | 2012-04-25 | Ncontact Surgical Inc | Vacuum coagulation probes |
JP5593545B2 (en) | 2006-12-06 | 2014-09-24 | メドトロニック シーブイ ルクセンブルク エス.アー.エール.エル. | System and method for transapical delivery of a self-expanding valve secured to an annulus |
US20080139887A1 (en) * | 2006-12-07 | 2008-06-12 | International Polymer Engineering, Inc. | Endoscopic working channel and method of making same |
US8236045B2 (en) | 2006-12-22 | 2012-08-07 | Edwards Lifesciences Corporation | Implantable prosthetic valve assembly and method of making the same |
WO2008103295A2 (en) | 2007-02-16 | 2008-08-28 | Medtronic, Inc. | Replacement prosthetic heart valves and methods of implantation |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
FR2915087B1 (en) | 2007-04-20 | 2021-11-26 | Corevalve Inc | IMPLANT FOR TREATMENT OF A HEART VALVE, IN PARTICULAR OF A MITRAL VALVE, EQUIPMENT INCLUDING THIS IMPLANT AND MATERIAL FOR PLACING THIS IMPLANT. |
US9126020B2 (en) | 2007-06-26 | 2015-09-08 | Roxwood Medical, Inc. | Catheter apparatus with telescoping lumen catheters and its use in methods for treating vasculatures |
US9125683B2 (en) | 2007-06-26 | 2015-09-08 | Roxwood Medical Inc. | Method and apparatus for placing a catheter within a vasculature |
ES2547490T3 (en) | 2007-06-26 | 2015-10-06 | Roxwood Medical, Inc. | Catheter apparatus and procedures to treat blood vessels |
US9566178B2 (en) | 2010-06-24 | 2017-02-14 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
US8052604B2 (en) * | 2007-07-31 | 2011-11-08 | Mirabilis Medica Inc. | Methods and apparatus for engagement and coupling of an intracavitory imaging and high intensity focused ultrasound probe |
US8747458B2 (en) | 2007-08-20 | 2014-06-10 | Medtronic Ventor Technologies Ltd. | Stent loading tool and method for use thereof |
US8100820B2 (en) * | 2007-08-22 | 2012-01-24 | Edwards Lifesciences Corporation | Implantable device for treatment of ventricular dilation |
DE102007043830A1 (en) | 2007-09-13 | 2009-04-02 | Lozonschi, Lucian, Madison | Heart valve stent |
DE202008018589U1 (en) | 2007-09-26 | 2016-03-14 | St. Jude Medical, Inc. | Foldable heart valve prostheses |
US9532868B2 (en) | 2007-09-28 | 2017-01-03 | St. Jude Medical, Inc. | Collapsible-expandable prosthetic heart valves with structures for clamping native tissue |
US10856970B2 (en) | 2007-10-10 | 2020-12-08 | Medtronic Ventor Technologies Ltd. | Prosthetic heart valve for transfemoral delivery |
US9848981B2 (en) | 2007-10-12 | 2017-12-26 | Mayo Foundation For Medical Education And Research | Expandable valve prosthesis with sealing mechanism |
US8529443B2 (en) * | 2007-10-31 | 2013-09-10 | James D. Maloney | Nasogastric tube for use during an ablation procedure |
US8506589B2 (en) * | 2007-10-31 | 2013-08-13 | James D. Maloney | Nasogastric tube for use during an ablation procedure |
US8187270B2 (en) * | 2007-11-07 | 2012-05-29 | Mirabilis Medica Inc. | Hemostatic spark erosion tissue tunnel generator with integral treatment providing variable volumetric necrotization of tissue |
US8439907B2 (en) * | 2007-11-07 | 2013-05-14 | Mirabilis Medica Inc. | Hemostatic tissue tunnel generator for inserting treatment apparatus into tissue of a patient |
EP4079261A1 (en) | 2007-12-14 | 2022-10-26 | Edwards Lifesciences Corporation | Leaflet attachment frame for a prosthetic valve |
WO2009094197A1 (en) | 2008-01-24 | 2009-07-30 | Medtronic, Inc. | Stents for prosthetic heart valves |
JP5687070B2 (en) | 2008-01-24 | 2015-03-18 | メドトロニック,インコーポレイテッド | Stent for prosthetic heart valve |
US9393115B2 (en) | 2008-01-24 | 2016-07-19 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
US9149358B2 (en) | 2008-01-24 | 2015-10-06 | Medtronic, Inc. | Delivery systems for prosthetic heart valves |
US8157852B2 (en) | 2008-01-24 | 2012-04-17 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
EP2254512B1 (en) * | 2008-01-24 | 2016-01-06 | Medtronic, Inc. | Markers for prosthetic heart valves |
WO2011104269A1 (en) | 2008-02-26 | 2011-09-01 | Jenavalve Technology Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
WO2009108355A1 (en) | 2008-02-28 | 2009-09-03 | Medtronic, Inc. | Prosthetic heart valve systems |
CA2961051C (en) | 2008-02-29 | 2020-01-14 | Edwards Lifesciences Corporation | Expandable member for deploying a prosthetic device |
US9241792B2 (en) | 2008-02-29 | 2016-01-26 | Edwards Lifesciences Corporation | Two-step heart valve implantation |
US8313525B2 (en) | 2008-03-18 | 2012-11-20 | Medtronic Ventor Technologies, Ltd. | Valve suturing and implantation procedures |
US8430927B2 (en) | 2008-04-08 | 2013-04-30 | Medtronic, Inc. | Multiple orifice implantable heart valve and methods of implantation |
US8312825B2 (en) | 2008-04-23 | 2012-11-20 | Medtronic, Inc. | Methods and apparatuses for assembly of a pericardial prosthetic heart valve |
US8696743B2 (en) | 2008-04-23 | 2014-04-15 | Medtronic, Inc. | Tissue attachment devices and methods for prosthetic heart valves |
US20090276040A1 (en) | 2008-05-01 | 2009-11-05 | Edwards Lifesciences Corporation | Device and method for replacing mitral valve |
US20100036294A1 (en) * | 2008-05-07 | 2010-02-11 | Robert Mantell | Radially-Firing Electrohydraulic Lithotripsy Probe |
US9061119B2 (en) * | 2008-05-09 | 2015-06-23 | Edwards Lifesciences Corporation | Low profile delivery system for transcatheter heart valve |
EP2119417B2 (en) | 2008-05-16 | 2020-04-29 | Sorin Group Italia S.r.l. | Atraumatic prosthetic heart valve prosthesis |
WO2009149462A2 (en) | 2008-06-06 | 2009-12-10 | Edwards Lifesciences Corporation | Low profile transcatheter heart valve |
US10702293B2 (en) | 2008-06-13 | 2020-07-07 | Shockwave Medical, Inc. | Two-stage method for treating calcified lesions within the wall of a blood vessel |
US9072534B2 (en) | 2008-06-13 | 2015-07-07 | Shockwave Medical, Inc. | Non-cavitation shockwave balloon catheter system |
JP5636363B2 (en) * | 2008-06-13 | 2014-12-03 | ディージェイティー、 エルエルシー | Shock wave balloon catheter device |
US8323335B2 (en) * | 2008-06-20 | 2012-12-04 | Edwards Lifesciences Corporation | Retaining mechanisms for prosthetic valves and methods for using |
WO2010008548A2 (en) | 2008-07-15 | 2010-01-21 | St. Jude Medical, Inc. | Collapsible and re-expandable prosthetic heart valve cuff designs and complementary technological applications |
US8109985B2 (en) * | 2008-07-23 | 2012-02-07 | Boston Scientific Scimed, Inc. | Occlusion crossing device and method |
US8216161B2 (en) * | 2008-08-06 | 2012-07-10 | Mirabilis Medica Inc. | Optimization and feedback control of HIFU power deposition through the frequency analysis of backscattered HIFU signals |
US9248318B2 (en) | 2008-08-06 | 2016-02-02 | Mirabilis Medica Inc. | Optimization and feedback control of HIFU power deposition through the analysis of detected signal characteristics |
US8652202B2 (en) | 2008-08-22 | 2014-02-18 | Edwards Lifesciences Corporation | Prosthetic heart valve and delivery apparatus |
EP2358307B1 (en) | 2008-09-15 | 2021-12-15 | Medtronic Ventor Technologies Ltd. | Prosthetic heart valve having identifiers for aiding in radiographic positioning |
US8721714B2 (en) | 2008-09-17 | 2014-05-13 | Medtronic Corevalve Llc | Delivery system for deployment of medical devices |
US9050449B2 (en) * | 2008-10-03 | 2015-06-09 | Mirabilis Medica, Inc. | System for treating a volume of tissue with high intensity focused ultrasound |
US8845559B2 (en) * | 2008-10-03 | 2014-09-30 | Mirabilis Medica Inc. | Method and apparatus for treating tissues with HIFU |
US8690936B2 (en) | 2008-10-10 | 2014-04-08 | Edwards Lifesciences Corporation | Expandable sheath for introducing an endovascular delivery device into a body |
US8137398B2 (en) | 2008-10-13 | 2012-03-20 | Medtronic Ventor Technologies Ltd | Prosthetic valve having tapered tip when compressed for delivery |
US8986361B2 (en) | 2008-10-17 | 2015-03-24 | Medtronic Corevalve, Inc. | Delivery system for deployment of medical devices |
US9180280B2 (en) * | 2008-11-04 | 2015-11-10 | Shockwave Medical, Inc. | Drug delivery shockwave balloon catheter system |
US9044618B2 (en) | 2008-11-05 | 2015-06-02 | Shockwave Medical, Inc. | Shockwave valvuloplasty catheter system |
EP2201911B1 (en) | 2008-12-23 | 2015-09-30 | Sorin Group Italia S.r.l. | Expandable prosthetic valve having anchoring appendages |
US8137345B2 (en) | 2009-01-05 | 2012-03-20 | Peak Surgical, Inc. | Electrosurgical devices for tonsillectomy and adenoidectomy |
US20100210899A1 (en) * | 2009-01-21 | 2010-08-19 | Tendyne Medical, Inc. | Method for percutaneous lateral access to the left ventricle for treatment of mitral insufficiency by papillary muscle alignment |
US20100217382A1 (en) * | 2009-02-25 | 2010-08-26 | Edwards Lifesciences | Mitral valve replacement with atrial anchoring |
US20110015476A1 (en) * | 2009-03-04 | 2011-01-20 | Jeff Franco | Devices and Methods for Treating Cardiomyopathy |
TW201039875A (en) * | 2009-03-31 | 2010-11-16 | Toray Industries | Guide wire and ablation catheter with balloon having the same |
BRPI0900752A2 (en) * | 2009-04-14 | 2010-12-28 | Nascimento Luiz Mauricio Soares Do | motor guide wire |
US8512397B2 (en) | 2009-04-27 | 2013-08-20 | Sorin Group Italia S.R.L. | Prosthetic vascular conduit |
GB2470716B (en) * | 2009-05-18 | 2013-10-23 | Cook Medical Technologies Llc | Thrombus retrieval device |
US8226566B2 (en) * | 2009-06-12 | 2012-07-24 | Flowcardia, Inc. | Device and method for vascular re-entry |
US8808369B2 (en) | 2009-10-05 | 2014-08-19 | Mayo Foundation For Medical Education And Research | Minimally invasive aortic valve replacement |
US8449599B2 (en) | 2009-12-04 | 2013-05-28 | Edwards Lifesciences Corporation | Prosthetic valve for replacing mitral valve |
WO2011072084A2 (en) | 2009-12-08 | 2011-06-16 | Avalon Medical Ltd. | Device and system for transcatheter mitral valve replacement |
US9226826B2 (en) | 2010-02-24 | 2016-01-05 | Medtronic, Inc. | Transcatheter valve structure and methods for valve delivery |
US8795354B2 (en) | 2010-03-05 | 2014-08-05 | Edwards Lifesciences Corporation | Low-profile heart valve and delivery system |
US8652204B2 (en) | 2010-04-01 | 2014-02-18 | Medtronic, Inc. | Transcatheter valve with torsion spring fixation and related systems and methods |
IT1400327B1 (en) | 2010-05-21 | 2013-05-24 | Sorin Biomedica Cardio Srl | SUPPORT DEVICE FOR VALVULAR PROSTHESIS AND CORRESPONDING CORRESPONDENT. |
JP2013526388A (en) | 2010-05-25 | 2013-06-24 | イエナバルブ テクノロジー インク | Artificial heart valve, and transcatheter delivery prosthesis comprising an artificial heart valve and a stent |
JP5848345B2 (en) | 2010-07-09 | 2016-01-27 | ハイライフ エスエーエス | Transcatheter atrioventricular valve prosthesis |
WO2012012761A2 (en) | 2010-07-23 | 2012-01-26 | Edwards Lifesciences Corporation | Retaining mechanisms for prosthetic valves |
US9918833B2 (en) | 2010-09-01 | 2018-03-20 | Medtronic Vascular Galway | Prosthetic valve support structure |
WO2012045030A2 (en) | 2010-10-01 | 2012-04-05 | Intrapace, Inc. | Feedback systems and methods to enhance obstructive and other obesity treatments, optionally using multiple sensors |
CN105380730B (en) | 2010-10-05 | 2018-08-17 | 爱德华兹生命科学公司 | Heart valve prosthesis |
DE202011111128U1 (en) | 2010-10-05 | 2020-05-27 | Edwards Lifesciences Corporation | Prosthetic heart valve |
WO2012061164A1 (en) | 2010-10-25 | 2012-05-10 | Kevin Mauch | Catheter apparatuses having multi-electrode arrays for renal neuromodulation and associated systems and methods |
EP2486894B1 (en) | 2011-02-14 | 2021-06-09 | Sorin Group Italia S.r.l. | Sutureless anchoring device for cardiac valve prostheses |
EP2486893B1 (en) | 2011-02-14 | 2017-07-05 | Sorin Group Italia S.r.l. | Sutureless anchoring device for cardiac valve prostheses |
US9155619B2 (en) | 2011-02-25 | 2015-10-13 | Edwards Lifesciences Corporation | Prosthetic heart valve delivery apparatus |
US9289282B2 (en) | 2011-05-31 | 2016-03-22 | Edwards Lifesciences Corporation | System and method for treating valve insufficiency or vessel dilatation |
US8979842B2 (en) | 2011-06-10 | 2015-03-17 | Medtronic Advanced Energy Llc | Wire electrode devices for tonsillectomy and adenoidectomy |
US8795357B2 (en) | 2011-07-15 | 2014-08-05 | Edwards Lifesciences Corporation | Perivalvular sealing for transcatheter heart valve |
US9119716B2 (en) | 2011-07-27 | 2015-09-01 | Edwards Lifesciences Corporation | Delivery systems for prosthetic heart valve |
EP4289398A3 (en) | 2011-08-11 | 2024-03-13 | Tendyne Holdings, Inc. | Improvements for prosthetic valves and related inventions |
US9827093B2 (en) | 2011-10-21 | 2017-11-28 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
US8574247B2 (en) | 2011-11-08 | 2013-11-05 | Shockwave Medical, Inc. | Shock wave valvuloplasty device with moveable shock wave generator |
CA3201836A1 (en) | 2011-12-09 | 2013-06-13 | Edwards Lifesciences Corporation | Prosthetic heart valve having improved commissure supports |
US9827092B2 (en) | 2011-12-16 | 2017-11-28 | Tendyne Holdings, Inc. | Tethers for prosthetic mitral valve |
EP2609893B1 (en) | 2011-12-29 | 2014-09-03 | Sorin Group Italia S.r.l. | A kit for implanting prosthetic vascular conduits |
WO2013109269A1 (en) | 2012-01-18 | 2013-07-25 | Bard Peripheral Vascular, Inc. | Vascular re-entry device |
CA2865013C (en) | 2012-02-22 | 2020-12-15 | Syntheon Cardiology, Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
US10159531B2 (en) | 2012-04-05 | 2018-12-25 | C. R. Bard, Inc. | Apparatus and methods relating to intravascular positioning of distal end of catheter |
US11759268B2 (en) | 2012-04-05 | 2023-09-19 | C. R. Bard, Inc. | Apparatus and methods relating to intravascular positioning of distal end of catheter |
JP2015516846A (en) | 2012-04-05 | 2015-06-18 | バード・アクセス・システムズ,インコーポレーテッド | Device and system for navigating and positioning a central venous catheter within a patient |
BR112014028131A2 (en) | 2012-05-11 | 2017-06-27 | Medtronic Ardian Luxembourg | catheter apparatus, renal neuromodulation system, and method for performing renal neuromodulation |
JP6416084B2 (en) | 2012-05-31 | 2018-10-31 | ベイリス メディカル カンパニー インコーポレイテッドBaylis Medical Company Inc. | Medical equipment |
US9642673B2 (en) | 2012-06-27 | 2017-05-09 | Shockwave Medical, Inc. | Shock wave balloon catheter with multiple shock wave sources |
WO2014022124A1 (en) | 2012-07-28 | 2014-02-06 | Tendyne Holdings, Inc. | Improved multi-component designs for heart valve retrieval device, sealing structures and stent assembly |
US9675454B2 (en) | 2012-07-30 | 2017-06-13 | Tendyne Holdings, Inc. | Delivery systems and methods for transcatheter prosthetic valves |
EP3895632A1 (en) | 2012-08-02 | 2021-10-20 | Bard Peripheral Vascular, Inc. | Ultrasound catheter system |
ES2715678T3 (en) | 2012-08-06 | 2019-06-05 | Shockwave Medical Inc | Low profile electrodes for an angioplasty shock wave catheter |
CA2881184C (en) | 2012-08-06 | 2019-06-04 | Shockwave Medical, Inc. | Shockwave catheter |
US9138249B2 (en) | 2012-08-17 | 2015-09-22 | Shockwave Medical, Inc. | Shock wave catheter system with arc preconditioning |
US9510946B2 (en) | 2012-09-06 | 2016-12-06 | Edwards Lifesciences Corporation | Heart valve sealing devices |
US9333000B2 (en) | 2012-09-13 | 2016-05-10 | Shockwave Medical, Inc. | Shockwave catheter system with energy control |
US9522012B2 (en) | 2012-09-13 | 2016-12-20 | Shockwave Medical, Inc. | Shockwave catheter system with energy control |
EP2908783B1 (en) | 2012-10-22 | 2020-08-05 | Roxwood Medical, Inc. | Apparatus for centering a microcatheter within a vasculature |
ES2931210T3 (en) | 2012-11-21 | 2022-12-27 | Edwards Lifesciences Corp | Retention Mechanisms for Prosthetic Heart Valves |
US9095321B2 (en) | 2012-11-21 | 2015-08-04 | Medtronic Ardian Luxembourg S.A.R.L. | Cryotherapeutic devices having integral multi-helical balloons and methods of making the same |
US9439763B2 (en) | 2013-02-04 | 2016-09-13 | Edwards Lifesciences Corporation | Prosthetic valve for replacing mitral valve |
US9168129B2 (en) | 2013-02-12 | 2015-10-27 | Edwards Lifesciences Corporation | Artificial heart valve with scalloped frame design |
CA2905107C (en) | 2013-03-11 | 2020-04-14 | Northgate Technologies Inc. | Unfocused electrohydraulic lithotripter |
US11937873B2 (en) | 2013-03-12 | 2024-03-26 | Boston Scientific Medical Device Limited | Electrosurgical device having a lumen |
US11116947B2 (en) * | 2013-03-15 | 2021-09-14 | W. L. Gore & Associates, Inc. | Balloon seal stress reduction and related systems and methods |
US9179974B2 (en) | 2013-03-15 | 2015-11-10 | Medtronic Ardian Luxembourg S.A.R.L. | Helical push wire electrode |
US10463489B2 (en) | 2013-04-02 | 2019-11-05 | Tendyne Holdings, Inc. | Prosthetic heart valve and systems and methods for delivering the same |
US11224510B2 (en) | 2013-04-02 | 2022-01-18 | Tendyne Holdings, Inc. | Prosthetic heart valve and systems and methods for delivering the same |
US9486306B2 (en) | 2013-04-02 | 2016-11-08 | Tendyne Holdings, Inc. | Inflatable annular sealing device for prosthetic mitral valve |
US10478293B2 (en) | 2013-04-04 | 2019-11-19 | Tendyne Holdings, Inc. | Retrieval and repositioning system for prosthetic heart valve |
EP2991586A1 (en) | 2013-05-03 | 2016-03-09 | Medtronic Inc. | Valve delivery tool |
CA2908342C (en) | 2013-05-20 | 2021-11-30 | Edwards Lifesciences Corporation | Prosthetic heart valve delivery apparatus |
US9610159B2 (en) | 2013-05-30 | 2017-04-04 | Tendyne Holdings, Inc. | Structural members for prosthetic mitral valves |
JP6461122B2 (en) | 2013-06-25 | 2019-01-30 | テンダイン ホールディングス,インコーポレイテッド | Thrombus management and structural compliance features of prosthetic heart valves |
EP3027144B1 (en) | 2013-08-01 | 2017-11-08 | Tendyne Holdings, Inc. | Epicardial anchor devices |
SG10202103500PA (en) | 2013-08-12 | 2021-05-28 | Mitral Valve Tech Sarl | Apparatus and methods for implanting a replacement heart valve |
CN105491978A (en) | 2013-08-30 | 2016-04-13 | 耶拿阀门科技股份有限公司 | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
US20150073515A1 (en) | 2013-09-09 | 2015-03-12 | Medtronic Ardian Luxembourg S.a.r.I. | Neuromodulation Catheter Devices and Systems Having Energy Delivering Thermocouple Assemblies and Associated Methods |
DE102013219509A1 (en) * | 2013-09-27 | 2015-04-02 | Olympus Winter & Ibe Gmbh | Expandable cooled electrode |
WO2015058039A1 (en) | 2013-10-17 | 2015-04-23 | Robert Vidlund | Apparatus and methods for alignment and deployment of intracardiac devices |
EP3656353A1 (en) | 2013-10-28 | 2020-05-27 | Tendyne Holdings, Inc. | Prosthetic heart valve and systems for delivering the same |
US9526611B2 (en) | 2013-10-29 | 2016-12-27 | Tendyne Holdings, Inc. | Apparatus and methods for delivery of transcatheter prosthetic valves |
US9352134B2 (en) | 2013-11-01 | 2016-05-31 | Biosense Webster (Israel) Ltd. | Segmented balloon catheter |
US9913715B2 (en) | 2013-11-06 | 2018-03-13 | St. Jude Medical, Cardiology Division, Inc. | Paravalvular leak sealing mechanism |
CR20160240A (en) | 2013-11-11 | 2016-08-04 | Edwards Lifesciences Cardiaq Llc | SYSTEMS AND METHODS FOR THE MANUFACTURE OF THE FRAME OF A CANNULA |
US9622863B2 (en) | 2013-11-22 | 2017-04-18 | Edwards Lifesciences Corporation | Aortic insufficiency repair device and method |
US10098734B2 (en) | 2013-12-05 | 2018-10-16 | Edwards Lifesciences Corporation | Prosthetic heart valve and delivery apparatus |
WO2015120122A2 (en) | 2014-02-05 | 2015-08-13 | Robert Vidlund | Apparatus and methods for transfemoral delivery of prosthetic mitral valve |
US9986993B2 (en) | 2014-02-11 | 2018-06-05 | Tendyne Holdings, Inc. | Adjustable tether and epicardial pad system for prosthetic heart valve |
AU2015229708B2 (en) | 2014-03-10 | 2019-08-15 | Tendyne Holdings, Inc. | Devices and methods for positioning and monitoring tether load for prosthetic mitral valve |
JP2017513600A (en) | 2014-04-24 | 2017-06-01 | メドトロニック アーディアン ルクセンブルク ソシエテ ア レスポンサビリテ リミテ | Nerve adjustment catheter with braided shaft and related systems and methods |
US9730715B2 (en) * | 2014-05-08 | 2017-08-15 | Shockwave Medical, Inc. | Shock wave guide wire |
EP3148448B1 (en) * | 2014-05-28 | 2018-04-04 | Boston Scientific Scimed, Inc. | Catheter with radiofrequency cutting tip and heated balloon |
US9532870B2 (en) | 2014-06-06 | 2017-01-03 | Edwards Lifesciences Corporation | Prosthetic valve for replacing a mitral valve |
US10195026B2 (en) | 2014-07-22 | 2019-02-05 | Edwards Lifesciences Corporation | Mitral valve anchoring |
US10058424B2 (en) | 2014-08-21 | 2018-08-28 | Edwards Lifesciences Corporation | Dual-flange prosthetic valve frame |
US10016272B2 (en) | 2014-09-12 | 2018-07-10 | Mitral Valve Technologies Sarl | Mitral repair and replacement devices and methods |
EP3242630A2 (en) | 2015-01-07 | 2017-11-15 | Tendyne Holdings, Inc. | Prosthetic mitral valves and apparatus and methods for delivery of same |
CA2975294A1 (en) | 2015-02-05 | 2016-08-11 | Tendyne Holdings, Inc. | Expandable epicardial pads and devices and methods for delivery of same |
WO2016134152A1 (en) * | 2015-02-18 | 2016-08-25 | Retrovascular, Inc. | Radiofrequency guidewire with controlled plasma generation and methods of use thereof |
US10327896B2 (en) | 2015-04-10 | 2019-06-25 | Edwards Lifesciences Corporation | Expandable sheath with elastomeric cross sectional portions |
US10792471B2 (en) | 2015-04-10 | 2020-10-06 | Edwards Lifesciences Corporation | Expandable sheath |
CA2983002C (en) | 2015-04-16 | 2023-07-04 | Tendyne Holdings, Inc. | Apparatus and methods for delivery, repositioning, and retrieval of transcatheter prosthetic valves |
US10064718B2 (en) | 2015-04-16 | 2018-09-04 | Edwards Lifesciences Corporation | Low-profile prosthetic heart valve for replacing a mitral valve |
US10010417B2 (en) | 2015-04-16 | 2018-07-03 | Edwards Lifesciences Corporation | Low-profile prosthetic heart valve for replacing a mitral valve |
US10709555B2 (en) | 2015-05-01 | 2020-07-14 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
US11446078B2 (en) | 2015-07-20 | 2022-09-20 | Megadyne Medical Products, Inc. | Electrosurgical wave generator |
WO2017042743A1 (en) | 2015-09-09 | 2017-03-16 | Baylis Medical Company Inc. | Epicardial access system & methods |
US10327894B2 (en) | 2015-09-18 | 2019-06-25 | Tendyne Holdings, Inc. | Methods for delivery of prosthetic mitral valves |
US10376364B2 (en) | 2015-11-10 | 2019-08-13 | Edwards Lifesciences Corporation | Implant delivery capsule |
US10470876B2 (en) | 2015-11-10 | 2019-11-12 | Edwards Lifesciences Corporation | Transcatheter heart valve for replacing natural mitral valve |
US11213344B2 (en) * | 2015-11-17 | 2022-01-04 | Biosense Webster (Israel) Ltd. | Guidewire with ablation and coagulation functionality |
WO2017087195A1 (en) | 2015-11-18 | 2017-05-26 | Shockwave Medical, Inc. | Shock wave electrodes |
ES2777609T3 (en) | 2015-12-03 | 2020-08-05 | Tendyne Holdings Inc | Framework Features for Prosthetic Mitral Valves |
CN108366859B (en) | 2015-12-28 | 2021-02-05 | 坦迪尼控股股份有限公司 | Atrial capsular bag closure for prosthetic heart valves |
US10179043B2 (en) | 2016-02-12 | 2019-01-15 | Edwards Lifesciences Corporation | Prosthetic heart valve having multi-level sealing member |
CA3216740A1 (en) | 2016-03-24 | 2017-09-28 | Edwards Lifesciences Corporation | Delivery system for prosthetic heart valve |
DE102016106478A1 (en) * | 2016-04-08 | 2017-10-12 | Biotronik Ag | Device for emitting energy and / or measuring electrical activity |
US10226265B2 (en) | 2016-04-25 | 2019-03-12 | Shockwave Medical, Inc. | Shock wave device with polarity switching |
US10470877B2 (en) | 2016-05-03 | 2019-11-12 | Tendyne Holdings, Inc. | Apparatus and methods for anterior valve leaflet management |
EP3454795B1 (en) | 2016-05-13 | 2023-01-11 | JenaValve Technology, Inc. | Heart valve prosthesis delivery system for delivery of heart valve prosthesis with introducer sheath and loading system |
EP3468480B1 (en) | 2016-06-13 | 2023-01-11 | Tendyne Holdings, Inc. | Sequential delivery of two-part prosthetic mitral valve |
WO2018005779A1 (en) | 2016-06-30 | 2018-01-04 | Tegels Zachary J | Prosthetic heart valves and apparatus and methods for delivery of same |
US11065116B2 (en) | 2016-07-12 | 2021-07-20 | Tendyne Holdings, Inc. | Apparatus and methods for trans-septal retrieval of prosthetic heart valves |
US11096781B2 (en) | 2016-08-01 | 2021-08-24 | Edwards Lifesciences Corporation | Prosthetic heart valve |
AU2017339980B2 (en) | 2016-10-06 | 2022-08-18 | Shockwave Medical, Inc. | Aortic leaflet repair using shock wave applicators |
US10973631B2 (en) | 2016-11-17 | 2021-04-13 | Edwards Lifesciences Corporation | Crimping accessory device for a prosthetic valve |
US10463484B2 (en) | 2016-11-17 | 2019-11-05 | Edwards Lifesciences Corporation | Prosthetic heart valve having leaflet inflow below frame |
US20180140321A1 (en) | 2016-11-23 | 2018-05-24 | C. R. Bard, Inc. | Catheter With Retractable Sheath And Methods Thereof |
US10603165B2 (en) | 2016-12-06 | 2020-03-31 | Edwards Lifesciences Corporation | Mechanically expanding heart valve and delivery apparatus therefor |
US10357264B2 (en) | 2016-12-06 | 2019-07-23 | Shockwave Medical, Inc. | Shock wave balloon catheter with insertable electrodes |
US11596726B2 (en) | 2016-12-17 | 2023-03-07 | C.R. Bard, Inc. | Ultrasound devices for removing clots from catheters and related methods |
US10758256B2 (en) | 2016-12-22 | 2020-09-01 | C. R. Bard, Inc. | Ultrasonic endovascular catheter |
US11654023B2 (en) | 2017-01-23 | 2023-05-23 | Edwards Lifesciences Corporation | Covered prosthetic heart valve |
US11185406B2 (en) | 2017-01-23 | 2021-11-30 | Edwards Lifesciences Corporation | Covered prosthetic heart valve |
US11013600B2 (en) | 2017-01-23 | 2021-05-25 | Edwards Lifesciences Corporation | Covered prosthetic heart valve |
CN110392557A (en) | 2017-01-27 | 2019-10-29 | 耶拿阀门科技股份有限公司 | Heart valve simulation |
US10582983B2 (en) | 2017-02-06 | 2020-03-10 | C. R. Bard, Inc. | Ultrasonic endovascular catheter with a controllable sheath |
US10441300B2 (en) | 2017-04-19 | 2019-10-15 | Shockwave Medical, Inc. | Drug delivery shock wave balloon catheter system |
US11020135B1 (en) | 2017-04-25 | 2021-06-01 | Shockwave Medical, Inc. | Shock wave device for treating vascular plaques |
US11135056B2 (en) | 2017-05-15 | 2021-10-05 | Edwards Lifesciences Corporation | Devices and methods of commissure formation for prosthetic heart valve |
EP3630013A4 (en) | 2017-05-22 | 2020-06-17 | Edwards Lifesciences Corporation | Valve anchor and installation method |
US20210401571A9 (en) | 2017-05-31 | 2021-12-30 | Edwards Lifesciences Corporation | Sealing member for prosthetic heart valve |
US10869759B2 (en) | 2017-06-05 | 2020-12-22 | Edwards Lifesciences Corporation | Mechanically expandable heart valve |
US11026785B2 (en) | 2017-06-05 | 2021-06-08 | Edwards Lifesciences Corporation | Mechanically expandable heart valve |
US10966737B2 (en) | 2017-06-19 | 2021-04-06 | Shockwave Medical, Inc. | Device and method for generating forward directed shock waves |
WO2019014473A1 (en) | 2017-07-13 | 2019-01-17 | Tendyne Holdings, Inc. | Prosthetic heart valves and apparatus and methods for delivery of same |
US10918473B2 (en) | 2017-07-18 | 2021-02-16 | Edwards Lifesciences Corporation | Transcatheter heart valve storage container and crimping mechanism |
KR102617878B1 (en) | 2017-08-11 | 2023-12-22 | 에드워즈 라이프사이언시스 코포레이션 | Sealing elements for artificial heart valves |
US11083575B2 (en) | 2017-08-14 | 2021-08-10 | Edwards Lifesciences Corporation | Heart valve frame design with non-uniform struts |
US10932903B2 (en) | 2017-08-15 | 2021-03-02 | Edwards Lifesciences Corporation | Skirt assembly for implantable prosthetic valve |
US10898319B2 (en) | 2017-08-17 | 2021-01-26 | Edwards Lifesciences Corporation | Sealing member for prosthetic heart valve |
US10973628B2 (en) | 2017-08-18 | 2021-04-13 | Edwards Lifesciences Corporation | Pericardial sealing member for prosthetic heart valve |
US10722353B2 (en) | 2017-08-21 | 2020-07-28 | Edwards Lifesciences Corporation | Sealing member for prosthetic heart valve |
JP7291124B2 (en) | 2017-08-28 | 2023-06-14 | テンダイン ホールディングス,インコーポレイテッド | Heart valve prosthesis with tethered connections |
CN107374726B (en) * | 2017-08-31 | 2023-10-20 | 绵阳立德电子股份有限公司 | Radio frequency ablation electrode needle with adjustable working length and mounting method |
US10973629B2 (en) | 2017-09-06 | 2021-04-13 | Edwards Lifesciences Corporation | Sealing member for prosthetic heart valve |
US11147667B2 (en) | 2017-09-08 | 2021-10-19 | Edwards Lifesciences Corporation | Sealing member for prosthetic heart valve |
US10709462B2 (en) | 2017-11-17 | 2020-07-14 | Shockwave Medical, Inc. | Low profile electrodes for a shock wave catheter |
CA3082622C (en) | 2017-12-05 | 2021-02-02 | Wesley Robert PEDERSEN | Transseptal guide wire puncture system |
EP3755270A1 (en) | 2018-02-22 | 2020-12-30 | Medtronic Vascular, Inc. | Prosthetic heart valve delivery systems and methods |
CN111918690B (en) * | 2018-03-29 | 2023-02-28 | 朝日英达科株式会社 | Catheter and reopening catheter system |
US11318011B2 (en) | 2018-04-27 | 2022-05-03 | Edwards Lifesciences Corporation | Mechanically expandable heart valve with leaflet clamps |
AU2018424859B2 (en) | 2018-05-23 | 2024-04-04 | Corcym S.R.L. | A cardiac valve prosthesis |
WO2019245746A1 (en) | 2018-06-21 | 2019-12-26 | Shockwave Medical, Inc. | System for treating occlusions in body lumens |
US11547475B2 (en) * | 2018-08-27 | 2023-01-10 | Mohamed A Basiony | System for its use in the treatment of vascular stenosis and occlusions |
KR20210082188A (en) | 2018-10-19 | 2021-07-02 | 에드워즈 라이프사이언시스 코포레이션 | Artificial heart valve with non-cylindrical frame |
US20200261154A1 (en) * | 2019-02-19 | 2020-08-20 | Asahi Intecc Co., Ltd. | Peripheral vessel tissue modification devices and methods of use thereof |
CN113873973B (en) | 2019-03-26 | 2023-12-22 | 爱德华兹生命科学公司 | prosthetic heart valve |
WO2021061294A1 (en) * | 2019-09-24 | 2021-04-01 | Shockwave Medical, Inc. | Low profile electrodes for a shock wave catheter |
EP4034006A1 (en) | 2019-09-24 | 2022-08-03 | Shockwave Medical, Inc. | System for treating thrombus in body lumens |
US11759190B2 (en) | 2019-10-18 | 2023-09-19 | Boston Scientific Medical Device Limited | Lock for medical devices, and related systems and methods |
US11801087B2 (en) | 2019-11-13 | 2023-10-31 | Boston Scientific Medical Device Limited | Apparatus and methods for puncturing tissue |
EP3831343B1 (en) | 2019-12-05 | 2024-01-31 | Tendyne Holdings, Inc. | Braided anchor for mitral valve |
US11724070B2 (en) | 2019-12-19 | 2023-08-15 | Boston Scientific Medical Device Limited | Methods for determining a position of a first medical device with respect to a second medical device, and related systems and medical devices |
US11648114B2 (en) | 2019-12-20 | 2023-05-16 | Tendyne Holdings, Inc. | Distally loaded sheath and loading funnel |
US11931098B2 (en) | 2020-02-19 | 2024-03-19 | Boston Scientific Medical Device Limited | System and method for carrying out a medical procedure |
US11819243B2 (en) | 2020-03-19 | 2023-11-21 | Boston Scientific Medical Device Limited | Medical sheath and related systems and methods |
US11951002B2 (en) | 2020-03-30 | 2024-04-09 | Tendyne Holdings, Inc. | Apparatus and methods for valve and tether fixation |
US11826075B2 (en) | 2020-04-07 | 2023-11-28 | Boston Scientific Medical Device Limited | Elongated medical assembly |
JP2023521165A (en) | 2020-06-17 | 2023-05-23 | ボストン サイエンティフィック メディカル デバイス リミテッド | electroanatomical mapping system |
US11938285B2 (en) | 2020-06-17 | 2024-03-26 | Boston Scientific Medical Device Limited | Stop-movement device for elongated medical assembly |
US11937796B2 (en) | 2020-06-18 | 2024-03-26 | Boston Scientific Medical Device Limited | Tissue-spreader assembly |
USD960356S1 (en) * | 2020-07-03 | 2022-08-09 | Baylis Medical Company Inc. | Piercing stylet with non-contacting distal tip |
WO2022039853A1 (en) | 2020-08-19 | 2022-02-24 | Tendyne Holdings, Inc. | Fully-transseptal apical pad with pulley for tensioning |
BR112023002487A2 (en) * | 2020-08-24 | 2023-05-02 | Edwards Lifesciences Corp | BALLOON COVER FOR A DISTRIBUTION APPLIANCE FOR AN EXPANDABLE PROSTHETIC HEART VALVE |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5350395A (en) | 1986-04-15 | 1994-09-27 | Yock Paul G | Angioplasty apparatus facilitating rapid exchanges |
US4762130A (en) | 1987-01-15 | 1988-08-09 | Thomas J. Fogarty | Catheter with corkscrew-like balloon |
US5178620A (en) | 1988-06-10 | 1993-01-12 | Advanced Angioplasty Products, Inc. | Thermal dilatation catheter and method |
US4998933A (en) | 1988-06-10 | 1991-03-12 | Advanced Angioplasty Products, Inc. | Thermal angioplasty catheter and method |
US4955377A (en) | 1988-10-28 | 1990-09-11 | Lennox Charles D | Device and method for heating tissue in a patient's body |
US5019042A (en) | 1988-11-23 | 1991-05-28 | Harvinder Sahota | Balloon catheters |
AU4945490A (en) | 1989-01-06 | 1990-08-01 | Angioplasty Systems Inc. | Electrosurgical catheter for resolving atherosclerotic plaque |
US5179961A (en) | 1989-04-13 | 1993-01-19 | Littleford Philip O | Catheter guiding and positioning method |
CA2067110C (en) | 1989-09-08 | 2001-07-31 | John E. Abele | Physiologic low stress angioplasty |
US5047026A (en) | 1989-09-29 | 1991-09-10 | Everest Medical Corporation | Electrosurgical implement for tunneling through tissue |
US5364393A (en) | 1990-07-02 | 1994-11-15 | Heart Technology, Inc. | Tissue dissipative recanalization catheter |
US5178618A (en) | 1991-01-16 | 1993-01-12 | Brigham And Womens Hospital | Method and device for recanalization of a body passageway |
US5683366A (en) | 1992-01-07 | 1997-11-04 | Arthrocare Corporation | System and method for electrosurgical tissue canalization |
US5419767A (en) | 1992-01-07 | 1995-05-30 | Thapliyal And Eggers Partners | Methods and apparatus for advancing catheters through severely occluded body lumens |
US5366443A (en) | 1992-01-07 | 1994-11-22 | Thapliyal And Eggers Partners | Method and apparatus for advancing catheters through occluded body lumens |
US5300068A (en) | 1992-04-21 | 1994-04-05 | St. Jude Medical, Inc. | Electrosurgical apparatus |
US5368566A (en) * | 1992-04-29 | 1994-11-29 | Cardiovascular Dynamics, Inc. | Delivery and temporary stent catheter having a reinforced perfusion lumen |
US5320605A (en) | 1993-01-22 | 1994-06-14 | Harvinder Sahota | Multi-wire multi-balloon catheter |
US5643171A (en) | 1993-05-04 | 1997-07-01 | Neocardia, Llc | Method and apparatus for uniform radiation treatment of vascular lumens |
EP0813894B1 (en) | 1993-07-01 | 2001-12-05 | Schneider (Europe) GmbH | Medical appliances for the treatment of blood vessels by means of ionizing radiation |
US5540659A (en) | 1993-07-15 | 1996-07-30 | Teirstein; Paul S. | Irradiation catheter and method of use |
US6196996B1 (en) | 1993-07-15 | 2001-03-06 | Paul S. Teirstein | Irradiation catheter and method of use |
EP0688580B1 (en) | 1994-06-24 | 2000-10-04 | Schneider (Europe) GmbH | Medical appliance for the treatment of a portion of body vessel by ionising radiation |
US5549551A (en) * | 1994-12-22 | 1996-08-27 | Advanced Cardiovascular Systems, Inc. | Adjustable length balloon catheter |
US5716389A (en) | 1995-11-13 | 1998-02-10 | Walinsky; Paul | Cardiac ablation catheter arrangement with movable guidewire |
CA2202421A1 (en) | 1996-05-29 | 1997-11-29 | Joseph P. Loeffler | Radiation-emitting flow-through temporary stent |
US5797948A (en) | 1996-10-03 | 1998-08-25 | Cordis Corporation | Centering balloon catheter |
US6217549B1 (en) | 1997-02-28 | 2001-04-17 | Lumend, Inc. | Methods and apparatus for treating vascular occlusions |
US5895400A (en) | 1997-06-27 | 1999-04-20 | Abela; George S. | Catheter with bristles |
US6081738A (en) | 1998-01-15 | 2000-06-27 | Lumend, Inc. | Method and apparatus for the guided bypass of coronary occlusions |
-
1999
- 1999-02-24 US US09/256,977 patent/US6210408B1/en not_active Expired - Fee Related
-
2000
- 2000-02-22 WO PCT/US2000/004475 patent/WO2000050115A2/en active Application Filing
-
2001
- 2001-03-20 US US09/814,142 patent/US6562031B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US6562031B2 (en) | 2003-05-13 |
WO2000050115A3 (en) | 2000-12-14 |
US20010012934A1 (en) | 2001-08-09 |
WO2000050115A2 (en) | 2000-08-31 |
US6210408B1 (en) | 2001-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6562031B2 (en) | Guide wire system for RF recanalization of vascular blockages | |
US6855143B2 (en) | Electrosurgical systems and methods for recanalization of occluded body lumens | |
US11266817B2 (en) | Cavitation catheter | |
JP6461891B2 (en) | Occluded vascular recanalization using high frequency energy | |
US6582423B1 (en) | Electrosurgical systems and methods for recanalization of occluded body lumens | |
JP6211576B2 (en) | Recanalization of occluded blood vessels using radio frequency energy | |
US11707289B2 (en) | Cavitation catheter | |
JP4187931B2 (en) | Inflatable catheter with two sets of electrodes and method of use | |
US6183469B1 (en) | Electrosurgical systems and methods for the removal of pacemaker leads | |
US5364393A (en) | Tissue dissipative recanalization catheter | |
WO2018013570A1 (en) | Bi-polar tissue ablation device and methods of use thereof | |
CN113473931A (en) | Peripheral vascular tissue modification devices and methods of use thereof | |
EP0465449B1 (en) | Tissue dissipative recanalization catheter. | |
WO2024039373A1 (en) | Balloon catheter with enhanced scoring capability |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
AK | Designated states |
Kind code of ref document: C2 Designated state(s): CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1/28-28/28, DRAWINGS, REPLACED BY NEW PAGES 1/25-25/25; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
122 | Ep: pct application non-entry in european phase |